Search by Journal
- HOME
- > Search by Journal
- > Japanese Journal of Transfusion and Cell Therapy
Japanese Journal of Transfusion and Cell Therapy
Volume 62, Issue 2 / 2016
English Article 
Japanese Article- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
|
Efforts for the present conditions of the SIL iPS cells study and the medical application 山中伸弥 Japanese Journal of Transfusion and Cell Therapy 62(2): 163-163, 2016. |
|---|
|
|
Cause PL step; way - leukemia, transfusion and cell therapy ... 前川平 Japanese Journal of Transfusion and Cell Therapy 62(2): 165-165, 2016. |
|---|
|
|
For thing - height and an expanse to aim at of the PRL blood business - 田所憲治 Japanese Journal of Transfusion and Cell Therapy 62(2): 167-167, 2016. |
|---|
|
|
Regenerative therapy <cell therapy science forum> of the SL-1 cornea 外園千恵 Japanese Journal of Transfusion and Cell Therapy 62(2): 169-169, 2016. |
|---|
|
SL-2 Updates with CAR and TCR Engineered T Cells for Cancer Barrett David Japanese Journal of Transfusion and Cell Therapy 62(2): 171-172, 2016. |
|---|
|
|
The disease of SL-3 humans is a ... size scale genome cohort and human biology in the study of humans 松田文彦 Japanese Journal of Transfusion and Cell Therapy 62(2): 174-174, 2016. |
|---|
|
|
Microenvironment (niche) to maintain SL-4 hematopoietic stem cells <cell therapy science forum> 長澤丘司 Japanese Journal of Transfusion and Cell Therapy 62(2): 176-176, 2016. |
|---|
|
|
Viral infection and the incompatible pregnancy which the aspect each other very small amount transfusion between ML mother children brings and society authorization system 大戸斉 Japanese Journal of Transfusion and Cell Therapy 62(2): 178-179, 2016. |
|---|
|
|
Examination of the transfusion second response frequency in the GL children transfusion medical care 柳沢龍1), 坂下一夫1), 西島史恵2), 下平滋隆3) Japanese Journal of Transfusion and Cell Therapy 62(2): 180-180, 2016. |
|---|
|
|
Treatment strategy of the EL-1 adult T cell leukemia 高折晃史 Japanese Journal of Transfusion and Cell Therapy 62(2): 181-181, 2016. |
|---|
|
|
EL-2 TRALI and TACO 岡崎仁 Japanese Journal of Transfusion and Cell Therapy 62(2): 182-182, 2016. |
|---|
|
|
Where is the DNA analysis of the EL-3 present age effective for an identification, blood relative judgment, the crime investigation to? 玉木敬二 Japanese Journal of Transfusion and Cell Therapy 62(2): 183-183, 2016. |
|---|
|
|
EL-4 disaster medical care and transfusion 小池薫 Japanese Journal of Transfusion and Cell Therapy 62(2): 184-184, 2016. |
|---|
|
|
An EL-5 Highway sequence technology and examination of transfusion infection 中屋隆明 Japanese Journal of Transfusion and Cell Therapy 62(2): 185-185, 2016. |
|---|
|
|
EL-6 fetal blood transfusion 室月淳 Japanese Journal of Transfusion and Cell Therapy 62(2): 186-186, 2016. |
|---|
|
|
The EL-7 medical care security system and team approach in medical care 松村由美 Japanese Journal of Transfusion and Cell Therapy 62(2): 187-187, 2016. |
|---|
|
|
Antibody for EL-8 autoantibody and the high incidence antigen 堀勇二 Japanese Journal of Transfusion and Cell Therapy 62(2): 188-188, 2016. |
|---|
|
|
About EL-9 posttransfusion hepatitis E 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 62(2): 189-189, 2016. |
|---|
|
|
EL-10 islet cell transplantation <cell therapy science forum> 穴澤貴行 Japanese Journal of Transfusion and Cell Therapy 62(2): 190-190, 2016. |
|---|
|
|
A function and structure of the red cell membrane Band 3 protein showing an EL-11 Diego type blood type 濱崎直孝 Japanese Journal of Transfusion and Cell Therapy 62(2): 191-191, 2016. |
|---|
|
|
CL-1 shaking, and going to where 川島実 Japanese Journal of Transfusion and Cell Therapy 62(2): 192-192, 2016. |
|---|
|
|
CL-2 "To force a thought.": Heaven and earth and man Relay of umbilical cord blood of life 巽良仁 Japanese Journal of Transfusion and Cell Therapy 62(2): 194-194, 2016. |
|---|
|
|
IS-1 Introduction for the collaborative study of allo-immunity in Asia Akihiro Takeshita Japanese Journal of Transfusion and Cell Therapy 62(2): 196-196, 2016. |
|---|
|
|
IS-2 The study of Irregular Antibodies for Erythrocyte in Japan Chiaki Yamada Japanese Journal of Transfusion and Cell Therapy 62(2): 197-197, 2016. |
|---|
|
|
IS-3 Irregular Antibodies for Erythrocyte in South Korea Kyou-Sup Han Japanese Journal of Transfusion and Cell Therapy 62(2): 198-198, 2016. |
|---|
|
|
IS-4 Transfusion Medicine and the Study of Irregular Antibodies for Erythrocyte in China Xianguo Xu1),2), Gang Deng3), Rongcang Chen4), Xiuwen Ni5), Jianhua Zhou6), Jiang Qian7), Shaoyun Wu8), Jiefeng Ding9), Ji He1),2), Faming Zhu1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 200-200, 2016. |
|---|
|
|
IS-5 The Study of Irregular Antibodies for Erythrocytes in Thailand Parichart Permpikul Japanese Journal of Transfusion and Cell Therapy 62(2): 202-202, 2016. |
|---|
|
|
IS-6 Irregular antibodies to erytrocytes in Malaysia Veera S.Nadarajan Japanese Journal of Transfusion and Cell Therapy 62(2): 204-205, 2016. |
|---|
|
|
HLA half agreement transplant using a little ATG and steroid for S-1-1 non-remission blood tumor 小川啓恭 Japanese Journal of Transfusion and Cell Therapy 62(2): 207-207, 2016. |
|---|
|
|
Transplant between safe HLA mismatch relatives using the S-1-2 monoclonal antibody (alemtuzumab) 神田善伸 Japanese Journal of Transfusion and Cell Therapy 62(2): 207-207, 2016. |
|---|
|
|
HLA half agreement transplant using cyclophosphamide a large quantity of after S-1-3 transplant 豊嶋崇徳 Japanese Journal of Transfusion and Cell Therapy 62(2): 208-208, 2016. |
|---|
|
|
Complications after the S-1-4 HLA haplo Aiden tical transplant 一戸辰夫 Japanese Journal of Transfusion and Cell Therapy 62(2): 208-208, 2016. |
|---|
|
|
Correspondence to massive bleeding during S-2-1 heart great vessels surgery 上田裕一 Japanese Journal of Transfusion and Cell Therapy 62(2): 209-209, 2016. |
|---|
|
|
From this of damage control resuscitation and the transfusion treatment for the S-2-2 serious case injury 久志本成樹 Japanese Journal of Transfusion and Cell Therapy 62(2): 209-209, 2016. |
|---|
|
|
For - guidelines development to think about optimal transfusion therapy for the acute hemostasis coagulation disorder in the S-2-3 massive bleeding - 宮田茂樹, 前田琢磨 Japanese Journal of Transfusion and Cell Therapy 62(2): 210-210, 2016. |
|---|
|
|
About blood administration to affect S-3-1 country self-support 近藤徹 Japanese Journal of Transfusion and Cell Therapy 62(2): 210-210, 2016. |
|---|
|
|
Report from the S-3-2 blood donation settings 細野晃 Japanese Journal of Transfusion and Cell Therapy 62(2): 211-211, 2016. |
|---|
|
|
From the situation of the S-3-3 hospital pharmacist 遠藤秀治 Japanese Journal of Transfusion and Cell Therapy 62(2): 211-211, 2016. |
|---|
|
|
From the situation of the S-3-4 Hospital transfusion section 奥田誠 Japanese Journal of Transfusion and Cell Therapy 62(2): 212-212, 2016. |
|---|
|
|
From the situation of the S-3-5 transfusion responsibility physician 牧野茂義 Japanese Journal of Transfusion and Cell Therapy 62(2): 212-212, 2016. |
|---|
|
|
Clinical study of the S-4-1 CD19-specific chimeric antigen receptor (CAR) therapy 大嶺謙 Japanese Journal of Transfusion and Cell Therapy 62(2): 213-213, 2016. |
|---|
|
|
Clinical development of the TCR gene modified T-cell (TCR-T) infusion therapy for S-4-2 intractable cancer 影山愼一 Japanese Journal of Transfusion and Cell Therapy 62(2): 213-213, 2016. |
|---|
|
|
Cancer immunotherapy using S-4-3 Vγ9Vδ2T cells 垣見和宏 Japanese Journal of Transfusion and Cell Therapy 62(2): 214-214, 2016. |
|---|
|
|
For development of the T-cell preparation which is usable in system of reproduction - heterogenous transplantation of the cancer antigen-specific killer cell using the S-4-4 iPS cells technology - 河本宏1), 増田喬子1), 前田卓也1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 214-214, 2016. |
|---|
|
|
Imaging of the platelet production process from S-5-1 blood megakaryocyte 古和田周吾 Japanese Journal of Transfusion and Cell Therapy 62(2): 215-215, 2016. |
|---|
|
|
A diagnosis and treatment of S-5-2 thrombocytopenia 冨山佳昭 Japanese Journal of Transfusion and Cell Therapy 62(2): 215-215, 2016. |
|---|
|
|
Choice of the new therapy based on plasma therapy and an etiology in the S-5-3 TMA 松本雅則 Japanese Journal of Transfusion and Cell Therapy 62(2): 216-216, 2016. |
|---|
|
|
Platelet transfusion therapy for S-5-4 thrombocytopenia 羽藤高明 Japanese Journal of Transfusion and Cell Therapy 62(2): 216-216, 2016. |
|---|
|
|
Applied possibility to treatment based on the characteristic of the S-6-1 humans mesenchyma system stem cell 三浦康生 Japanese Journal of Transfusion and Cell Therapy 62(2): 217-217, 2016. |
|---|
|
|
GVHD treatment using the S-6-2 mesenchyma system stem cell 村田誠 Japanese Journal of Transfusion and Cell Therapy 62(2): 217-217, 2016. |
|---|
|
|
Bone regeneration treatment for the congenital systemic bone disease using the S-6-3 same kind mesenchyma system stem cell 竹谷健 Japanese Journal of Transfusion and Cell Therapy 62(2): 218-218, 2016. |
|---|
|
|
For chylopoietic disease treatment - first-in-human clinical study using the pro-mesenchyma derived from S-6-4 amnion stem cell - 大西俊介 Japanese Journal of Transfusion and Cell Therapy 62(2): 218-218, 2016. |
|---|
|
|
Basic knowledge of the S-7-1 myelodysplastic syndrome 原田浩徳 Japanese Journal of Transfusion and Cell Therapy 62(2): 219-219, 2016. |
|---|
|
|
A diagnosis and treatment of S-7-2 aplastic anemia 山崎宏人 Japanese Journal of Transfusion and Cell Therapy 62(2): 219-219, 2016. |
|---|
|
|
New treatment strategy with the molecular target therapy for S-7-3 marrow proliferative tumor 南陽介 Japanese Journal of Transfusion and Cell Therapy 62(2): 220-220, 2016. |
|---|
|
|
The basic knowledge of the S-7-4 transfusion second response and the management 芦田隆司 Japanese Journal of Transfusion and Cell Therapy 62(2): 220-220, 2016. |
|---|
|
|
S-8-1 HLA antigens technique 高陽淑 Japanese Journal of Transfusion and Cell Therapy 62(2): 221-221, 2016. |
|---|
|
|
Clinical significance of HLA antigens in the S-8-2 hematopoietic stem cell transplantation 吉原哲 Japanese Journal of Transfusion and Cell Therapy 62(2): 221-221, 2016. |
|---|
|
|
S-8-3 organ transplantation and HLA antigens 万木紀美子 Japanese Journal of Transfusion and Cell Therapy 62(2): 222-222, 2016. |
|---|
|
|
About problems of the S-8-4 antiHLA antigens technique and the need of unifying it 田中秀則 Japanese Journal of Transfusion and Cell Therapy 62(2): 222-222, 2016. |
|---|
|
|
About an introduction effect of the S-9-1 individual treatment NAT 坂本賢一 Japanese Journal of Transfusion and Cell Therapy 62(2): 223-223, 2016. |
|---|
|
|
About alloimmunity measures by the leukopheresis before S-9-2 preservation (prevention effect of the HLA antibody production) 石井博之 Japanese Journal of Transfusion and Cell Therapy 62(2): 223-223, 2016. |
|---|
|
|
About a prevention effect of the bacteria pollution by the leukopheresis and first bloodshed removal before S-9-3 preservation 名雲英人 Japanese Journal of Transfusion and Cell Therapy 62(2): 224-224, 2016. |
|---|
|
|
About supply of the antigen-negative blood for the S-9-4 irregularity antibody possession patients 石丸健 Japanese Journal of Transfusion and Cell Therapy 62(2): 224-224, 2016. |
|---|
|
|
About a clinical culture person authorization system in the S-10-1 Japan regenerative therapy society 江副幸子 Japanese Journal of Transfusion and Cell Therapy 62(2): 225-225, 2016. |
|---|
|
|
From S-10-2 clinical culture person acquisition experience 笠井泰成 Japanese Journal of Transfusion and Cell Therapy 62(2): 225-225, 2016. |
|---|
|
|
About S-10-3 cell therapy authorization management teacher system 長村 (井上) 登紀子 Japanese Journal of Transfusion and Cell Therapy 62(2): 226-226, 2016. |
|---|
|
|
S-10-4 cell therapy authorization management teacher and regenerative therapy clinical culture person 伊藤経夫 Japanese Journal of Transfusion and Cell Therapy 62(2): 226-226, 2016. |
|---|
|
|
Significance and problem of the regenerative therapy-related new system judging from the S-10-5 industry side 畠賢一郎 Japanese Journal of Transfusion and Cell Therapy 62(2): 227-227, 2016. |
|---|
|
|
About the situation after the enforcement of the safe security method such as S-10-6 regenerative therapy 神ノ田昌博 Japanese Journal of Transfusion and Cell Therapy 62(2): 227-227, 2016. |
|---|
|
|
S-11-1 The Current State of Pathogen Inactivation-Looking at Factors that Influence Adoption Richard Benjamin Japanese Journal of Transfusion and Cell Therapy 62(2): 228-228, 2016. |
|---|
|
|
S-11-2 Assessing Cost Implications when Implementing Pathogen Inactivation Technology Dawn Ward Japanese Journal of Transfusion and Cell Therapy 62(2): 228-228, 2016. |
|---|
|
|
S-11-3 The Hong Kong Blood Transfusion Service (HKBTS) Experience with the INTERCEPT Blood System Albert Lie Japanese Journal of Transfusion and Cell Therapy 62(2): 229-229, 2016. |
|---|
|
|
Comparison of the ingredient of the S-12-1 fibrin paste 牧野茂義 Japanese Journal of Transfusion and Cell Therapy 62(2): 229-229, 2016. |
|---|
|
|
It is usefulness ... of the wound region processing with a ... PGA sheet and the self blood origin fibrin paste about an episode of care of the wound part coating using the self-blood in the S-12-2 oral surgery surgery 纐纈衆 Japanese Journal of Transfusion and Cell Therapy 62(2): 230-230, 2016. |
|---|
|
|
Usefulness of the self-fibrin paste in the S-12-3 nasal base of skull surgery 西岡宏1), 牧野茂義2), 福原紀章1), 岡田満夫1), 山田正三1) Japanese Journal of Transfusion and Cell Therapy 62(2): 230-230, 2016. |
|---|
|
|
Effect and inspection of the clinical evidence about the perioperative bleeding risk of infection to give an increase, the differentiation of the stem cell of the S-12-4 self cryoprecipitate 池田敏之, 川端みちる, 高柳俊作, 牧宏彰, 名倉豊, 正本庸介, 曽根伸治, 岡崎仁 Japanese Journal of Transfusion and Cell Therapy 62(2): 231-231, 2016. |
|---|
|
|
Use of the self-fibrin paste in the S-12-5 gastrointestinal tract anastomosis 木ノ下義宏1), 樫村暢一1), 成田吉明1), 中村文隆1), 安保義恭1), 加藤弘明1), 高田実1), 早馬聡1), 阿部大1), 田畑佑希子1), 今村清隆1), 寺村紘一1), 武内慎太郎1), 三浦邦彦2) Japanese Journal of Transfusion and Cell Therapy 62(2): 231-231, 2016. |
|---|
|
|
The present conditions of S-13-1 society authorization, the autotransfusion responsibility physician system and future development 脇本信博 Japanese Journal of Transfusion and Cell Therapy 62(2): 232-232, 2016. |
|---|
|
|
The expansion of S-13-2 society authorization, the autotransfusion nurse system and future problem 小松久美子 Japanese Journal of Transfusion and Cell Therapy 62(2): 232-232, 2016. |
|---|
|
|
For promotion of the preserved blood-style autotransfusion that is safe in S-13-3 appropriateness 安村敏, 島京子 Japanese Journal of Transfusion and Cell Therapy 62(2): 233-233, 2016. |
|---|
|
|
The cooperation system of a physician and the nurse in the S-13-4 preserved blood type autotransfusion 川住妙子1), 山本香世1), 高橋和寛2) Japanese Journal of Transfusion and Cell Therapy 62(2): 233-233, 2016. |
|---|
|
|
Role of the medical technologist in the S-13-5 preserved blood type autotransfusion 府川正儀, 牧野茂義 Japanese Journal of Transfusion and Cell Therapy 62(2): 234-234, 2016. |
|---|
|
|
Approach to prevention of transfusion blunder by the S-14-1 medical technologist 河原好絵, 渡辺直樹, 大塚浩平, 高橋裕之, 友田豊, 花田大輔, 藤井聡 Japanese Journal of Transfusion and Cell Therapy 62(2): 234-234, 2016. |
|---|
|
|
Efforts - surgery section - to prevention of transfusion blunder by the S-14-2 nurse 豊島麻実 Japanese Journal of Transfusion and Cell Therapy 62(2): 235-235, 2016. |
|---|
|
|
Efforts from S-14-3 anesthesiologist to prevention of transfusion blunder to see 前田琢磨, 金海仁在, 川村知織, 瀬口周, 児玉眞由美, 河合健, 宮田茂樹 Japanese Journal of Transfusion and Cell Therapy 62(2): 235-235, 2016. |
|---|
|
|
S-14-4 Ideal and the reality of blood transfusion accident measures 辰巳陽一 Japanese Journal of Transfusion and Cell Therapy 62(2): 236-236, 2016. |
|---|
|
|
Developmental process of the organ to visualize by S-15-1 single cell analysis 渡辺亮 Japanese Journal of Transfusion and Cell Therapy 62(2): 236-236, 2016. |
|---|
|
|
S-15-2 In vivo generation of transplantable marine hematopoietic stem cells from iPS Cells. Satoshi Yamazaki Japanese Journal of Transfusion and Cell Therapy 62(2): 237-237, 2016. |
|---|
|
|
Development present conditions report for the clinical study of the platelet derived from S-15-3 iPS cells 江藤浩之 Japanese Journal of Transfusion and Cell Therapy 62(2): 237-237, 2016. |
|---|
|
|
Creation of the human organ by the organ-anlage transplant derived from S-15-4 iPS cells 武部貴則 Japanese Journal of Transfusion and Cell Therapy 62(2): 238-238, 2016. |
|---|
|
|
From the situation of term - clinical transfusion nurse of the S-16-1 chairmanship - 松本真弓 Japanese Journal of Transfusion and Cell Therapy 62(2): 238-238, 2016. |
|---|
|
|
From the situation of the S-16-2 cancer chemotherapy nursing authorization nurse 土井久容 Japanese Journal of Transfusion and Cell Therapy 62(2): 239-239, 2016. |
|---|
|
|
From the situation of the S-16-3 emergency care authorization nurse 清水克彦 Japanese Journal of Transfusion and Cell Therapy 62(2): 239-239, 2016. |
|---|
|
|
From the situation of the S-16-4 transfusion responsibility physician 河野武弘 Japanese Journal of Transfusion and Cell Therapy 62(2): 240-240, 2016. |
|---|
|
|
Future image of S-16-5 society authorization, the clinical transfusion nurse 大戸斉1), 田崎哲典2) Japanese Journal of Transfusion and Cell Therapy 62(2): 240-240, 2016. |
|---|
|
|
Serologic characteristic of the S-17-1 JR blood type 内川誠 Japanese Journal of Transfusion and Cell Therapy 62(2): 241-241, 2016. |
|---|
|
|
Mutation in the gene of the S-17-2 JR system 田中光信 Japanese Journal of Transfusion and Cell Therapy 62(2): 241-241, 2016. |
|---|
|
|
Production of Jra with the S-17-3 pregnancy, the transfusion and the clinical significance 伊藤正一, 荻山佳子, 鈴木光, 峯岸正好, 清水博 Japanese Journal of Transfusion and Cell Therapy 62(2): 242-242, 2016. |
|---|
|
|
Mechanism of clinical picture of the S-17-4 Jra incompatible pregnancy and fetal anemia 柏木浩和1), 藤田聡子2), 冨松拓治2), 木村正2), 冨山佳昭1),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 242-242, 2016. |
|---|
|
|
S-17-5 gout, hyperuricaemia and Jra antigen 松尾洋孝 Japanese Journal of Transfusion and Cell Therapy 62(2): 243-243, 2016. |
|---|
|
|
Adopt the training of the transfusion nursing in the in-hospital continuing education of the WS-1-1 nursing department 三井優 Japanese Journal of Transfusion and Cell Therapy 62(2): 244-244, 2016. |
|---|
|
|
Transfusion education in the WS-1-2 surgery section 日南淳子1), 池添香苗1), 平原由喜枝1), 向井梢1), 柳田咲也香1), 河野武弘2) Japanese Journal of Transfusion and Cell Therapy 62(2): 244-244, 2016. |
|---|
|
|
Autotransfusion visit study session by the WS-1-3 Saitama autotransfusion subcommittee 木村秀実1),2), 池淵研二2),3), 村上純子2),4), 石上園子2),5), 渡邉一儀2),6), 長谷川卓也2),7), 田中良2),8) Japanese Journal of Transfusion and Cell Therapy 62(2): 245-245, 2016. |
|---|
|
|
Use ... of invention - simulation demonstration and e-learning of the study session as the in-hospital activity of WS-1-4 society authorization, the clinical transfusion nurse 工藤柳子1), 西塚和美1),2), 乗田生子1), 大野優輝子1), 高橋慎子1), 中山千晶1), 築舘ルミ子1), 喜多島直美1), 菊池貴子1), 山片りゅう子1), 山口千鶴2), 山本磨知子2), 北澤淳一2),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 245-245, 2016. |
|---|
|
|
WS-2-1 ISBT platelet group, granulocytes type workshop report 岡崎仁 Japanese Journal of Transfusion and Cell Therapy 62(2): 246-246, 2016. |
|---|
|
|
About WS-2-2 HNA-3a antibody and TRALI 鎌田裕美1), 中村淳子1), 中島文明1), 牧野茂義2), 正本庸介3), 岡崎仁3), 石野田正純4), 梶本昌子4), 平力造4), 石川善英1), 永井正1), 佐竹正博1) Japanese Journal of Transfusion and Cell Therapy 62(2): 246-246, 2016. |
|---|
|
|
Significance of the neutrophil associated IgG measurement in the WS-2-3 autoimmunity-related neutropenia 宮崎孔1), 東寛2), 松林圭二1), 佐藤進一郎1), 加藤俊明1), 池田久實3), 紀野修一1), 山本哲3), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 247-247, 2016. |
|---|
|
|
Analysis of the antiHPA-15 antibody in the WS-2-4 platelet transfusion refractoriness (PTR) case 小林洋紀1), 高田慎之介1), 武田直也1), 東史啓1), 柏瀬貢一1), 鈴木雅治1), 中島一格1), 牧野茂義2) Japanese Journal of Transfusion and Cell Therapy 62(2): 247-247, 2016. |
|---|
|
|
Significance of the antiHPA-4b antibody in the WS-2-5 liver transplantation 松橋美佳1),2), 津野寛和2), 川端みちる2), 伊井野潤子2), 池田敏之2), 岡崎仁2) Japanese Journal of Transfusion and Cell Therapy 62(2): 248-248, 2016. |
|---|
|
|
Activity report of the nurse at WS-3-1 Aomori combination transfusion therapy Committee sectional meeting 西塚和美1),2), 乗田生子1),2), 塗谷智子2),3), 小笠原圭子2),4), 境峰子2),5), 玉井佳子6),7), 立花直樹6),8), 北澤淳一6),8) Japanese Journal of Transfusion and Cell Therapy 62(2): 249-249, 2016. |
|---|
|
|
About the activity actual situation after the WS-3-2 society authorized nursing license acquisition - Aomori combination transfusion therapy Committee questionnaire findings - 立花直樹1),3), 玉井佳子1),4), 西塚和美2),5), 塗谷智子2),6), 境峰子2),7), 小笠原圭子2),8), 北澤淳一1),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 249-249, 2016. |
|---|
|
|
WS-3-3 Gifu combination transfusion therapy Committee report (the second report) 小杉浩史1),10), 兼村信宏2),10), 南谷泰仁3),10), 北川順一3),10), 高橋健4),10), 八木良仁5),10), 佐藤弦士朗3),10), 伊藤裕子1),10), 福岡玲6),10), 帖佐光洋3),10), 臼田直美4),10), 樋口布抄子7),10), 多和田嘉明8),10), 森美恵子1),10), 中永徳子4),10), 林勝知9),10), 清島満3),10) Japanese Journal of Transfusion and Cell Therapy 62(2): 250-250, 2016. |
|---|
|
|
Past, present, future ... committee of WS-3-4 Mie transfusion therapy Committee is ... from problems to hold 玉木茂久1),10), 大石晃嗣2),10), 川上恵基3),10), 岡宏次4),10), 井上千好5),10), 足立千鶴6),10), 大西まり1),10), 岡田昌彦7),10), 今井重美7),10), 中正純8),10), 南信行9),10) Japanese Journal of Transfusion and Cell Therapy 62(2): 250-250, 2016. |
|---|
|
|
About the questionnaire findings about "transfusion management" by WS-3-5 Akita combination transfusion therapy Committee and "the inspection system" 吉田斉1), 國井華子1), 小塚源儀2), 林崎久美子3), 寺田亨1), 二部琴美1), 鎌田博子1), 阿部真1), 面川進1) Japanese Journal of Transfusion and Cell Therapy 62(2): 251-251, 2016. |
|---|
|
|
RC-1 when "Here we go was in trouble, and do not come, what would do? "Introduction 笹田裕司1), 岩尾憲明2), 友田豊3), 日高陽子4), 丸山美津子5), 松本雅則6), 奥田誠7) Japanese Journal of Transfusion and Cell Therapy 62(2): 252-252, 2016. |
|---|
|
|
How do you choose the RC-2 antigen-negative blood? 山本喜則 Japanese Journal of Transfusion and Cell Therapy 62(2): 252-252, 2016. |
|---|
|
|
RC-3 Front and back mismatch? Moreover, different from the results of the past! 松浦秀哲 Japanese Journal of Transfusion and Cell Therapy 62(2): 253-253, 2016. |
|---|
|
|
There is not an effect of the RC-4 platelet transfusion! 井手大輔 Japanese Journal of Transfusion and Cell Therapy 62(2): 253-253, 2016. |
|---|
|
|
TS-1 Handling of cell preparation as a medicine: For human bone marrow-derived mesenchymal stem cell TEM cell HS injection to adapt the acute GVHD after hematopoietic stem cell transplantation 室井一男 Japanese Journal of Transfusion and Cell Therapy 62(2): 254-254, 2016. |
|---|
|
|
From the sampling of TS-2 granulocytes to infusion, actually 藤盛好啓 Japanese Journal of Transfusion and Cell Therapy 62(2): 254-254, 2016. |
|---|
|
|
Observance matter about the quality control in TS-3 hematopoietic stem cell transplantation, the cell therapy 小嶋俊介1), 下平滋隆1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 255-255, 2016. |
|---|
|
|
TS-4 Q&A (follow cells handling text) 松本真弓1), 上村知恵2), 上田恭典3) Japanese Journal of Transfusion and Cell Therapy 62(2): 255-255, 2016. |
|---|
|
|
BU-1 - obstetric edition - of the safe pre-operative autologous blood donation made with the system 村田真由美 Japanese Journal of Transfusion and Cell Therapy 62(2): 256-256, 2016. |
|---|
|
|
Role of the apheresis nurse in the nurse at BU-2 blood center 渡邉美奈, 齋藤和枝, 鈴木香織, 渡辺樹里, 仙波ゆかり, 馬越恵子, 菅野隆浩, 今野金裕 Japanese Journal of Transfusion and Cell Therapy 62(2): 256-256, 2016. |
|---|
|
|
Role as the BU-3 clinical transfusion nurse Hospital training institution 藤理沙 Japanese Journal of Transfusion and Cell Therapy 62(2): 257-257, 2016. |
|---|
|
|
Activity of nurse at BU-4 northeast Branch promotion Committee 鈴木桂子1),2), 北澤淳一1), 西塚和美1), 根津小百合1), 片野めぐみ1), 上村克子1), 境峰子1), 塗谷智子1), 小笠原圭子1), 高橋智子1), 樋渡佳代子1), 佐々木夫起子1), 佐藤ルミ子1), 黒田敏子1), 大戸斉1) Japanese Journal of Transfusion and Cell Therapy 62(2): 257-257, 2016. |
|---|
|
|
About the nurse training by BU-5 Akita combination transfusion therapy Committee 上村克子1),5), 國井華子4), 吉田斉4), 樋渡佳代子2),5), 藤島直仁3),5), 阿部真4),5), 面川進4),5) Japanese Journal of Transfusion and Cell Therapy 62(2): 258-258, 2016. |
|---|
|
|
The work that you should do after acquiring transfusion medical care series third - qualification that BU-6 nurse should know 水田秀一 Japanese Journal of Transfusion and Cell Therapy 62(2): 258-258, 2016. |
|---|
|
|
About completion of TF-1 patients security guide (transfusion edition) Ver .1.0 and development of the future taskforce 大谷慎一 Japanese Journal of Transfusion and Cell Therapy 62(2): 259-259, 2016. |
|---|
|
|
Participate in TF-2 hospital information system taskforce, the patients security guide development team 坂本大 Japanese Journal of Transfusion and Cell Therapy 62(2): 259-259, 2016. |
|---|
|
|
Pilot study for the purpose of the traceability introduction of TF-3 blood products 浜口功 Japanese Journal of Transfusion and Cell Therapy 62(2): 260-260, 2016. |
|---|
|
|
About TF-4 "patients security guide (transfusion edition) Ver .1.0 of the JAHIS medical information system" establishment 並川寛和 Japanese Journal of Transfusion and Cell Therapy 62(2): 260-260, 2016. |
|---|
|
|
About the case which did not develop TRALI with platelet preparation of the division production to hold O-1 HNA-3a antibody together 鎌田裕美1), 中村淳子1), 中島文明1), 牧野茂義2), 正本庸介3), 岡崎仁3), 石野田正純4), 梶本昌子4), 平力造4), 石川善英1), 永井正1), 佐竹正博1) Japanese Journal of Transfusion and Cell Therapy 62(2): 263-263, 2016. |
|---|
|
|
About usefulness of the granulocytes agglutination in the investigation of the patient factors about the O-2 TRALI case 尼岸悦子, 入江與利子, 松山宣樹, 保井一太, 石井博之, 松倉晴道, 藤村吉博, 平山文也 Japanese Journal of Transfusion and Cell Therapy 62(2): 263-263, 2016. |
|---|
|
|
Property analysis of the neutrophilic priming factor in patients with O-3 blood transfusion reaction onset 高橋大輔1),2), 松林圭二1), 佐藤進一郎1), 加藤俊明1), 山本哲2), 池田久實2), 紀野修一1), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 264-264, 2016. |
|---|
|
|
Identification of the mast cell degranulation reinforcement factor which fresh frozen plasma preparation used in the O-4 blood transfusion reaction case that is non-hemolytic contains 阿部高秋, 渡辺嘉久, 石川善英, 永井正, 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 62(2): 264-264, 2016. |
|---|
|
|
Examination of the hemocyte activation study to do neutrophils, a monocyte, basophils, a platelet for the purpose of the cause investigation of the O-5 blood transfusion reaction case that is non-hemolytic if targeted for analysis 松山宣樹, 尼岸悦子, 入江與利子, 保井一太, 石井博之, 松倉晴道, 藤村吉博, 平山文也 Japanese Journal of Transfusion and Cell Therapy 62(2): 265-265, 2016. |
|---|
|
|
Patients blood and examination (the second report) of the basophils activated study using the platelet rest sample concerned that developed O-6 anaphylaxis 岡村郁恵1), 松山宣樹2), 深谷真史1), 梁瀬博文3), 平山文也2), 池田宇次1) Japanese Journal of Transfusion and Cell Therapy 62(2): 265-265, 2016. |
|---|
|
|
The present conditions of the peripheral blood CD34 positive cells measurement before sampling in the O-7 peripheral blood stem cell sampling 吉本千尋1), 崔日承3), 稲垣二郎2) Japanese Journal of Transfusion and Cell Therapy 62(2): 266-266, 2016. |
|---|
|
|
Efforts to peripheral blood stem cell sampling time shortening by the O-8 quickness CD34 counts measurement 佐藤勉1), 玉井洋太郎2) Japanese Journal of Transfusion and Cell Therapy 62(2): 266-266, 2016. |
|---|
|
|
National multicenter study on CD34-positive cytometric outside evaluation using the O-9 fixation blood corpuscle (breaking news) 原口京子1),9), 奥山美樹1), 高橋典子2),9), 河原好絵3),9), 酒井紫緒4),9), 上村知恵5),9), 渡邊直英5),9), 長村(井上)登紀子6),9), 高梨美乃子7),9), 上田恭典8),9), 田野崎隆二2),9) Japanese Journal of Transfusion and Cell Therapy 62(2): 267-267, 2016. |
|---|
|
|
About the usefulness of the hematopoietic progenitor cells (HPC) assay with the automatic blood corpuscle analyzer in the O-10 peripheral blood stem cell sampling: Rearward analysis in the single institution for 9 years 田中宏明1),2), 佐藤文美2), 石井昭広1), 岩井利恵2) Japanese Journal of Transfusion and Cell Therapy 62(2): 267-267, 2016. |
|---|
|
|
Usefulness of hematopoietic progenitor cells hematopoietic progenitor cell (HPC) at the O-11 peripheral blood stem cell sampling decision 小林美希1),2), 高原幸恵2), 武藤かほる2), 松田章子3), 中村正史2), 内田俊樹1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 268-268, 2016. |
|---|
|
|
Construction of quantity of O-12 self peripheral blood hematopoietic stem cells sampling high precision prediction program ASNE (Apheresis Stem cell Number Equation) and the clinical application 牧宏彰1), 佐藤智彦1),2), 正本庸介1), 高柳俊作1), 池田敏之1), 岡崎仁1) Japanese Journal of Transfusion and Cell Therapy 62(2): 268-268, 2016. |
|---|
|
|
Quantity of optimal pre-operative autologous blood donation of a preliminary remark, the low lying placenta case in the O-13 preserved blood-type self-blood 酒井あゆみ1), 松永茂剛2), 舘明子3), 阿南昌弘3), 江良澄子1), 高井泰2), 斉藤正博1), 山本晃士3), 関博之1), 前田平生3) Japanese Journal of Transfusion and Cell Therapy 62(2): 269-269, 2016. |
|---|
|
|
Blood vessel vagus nerve response measures by the obstetric self-blood drawing blood in the O-14 our hospital 藤田浩1), 高田裕子2), 五十嵐朋子2), 浅香祐幸2), 中原美千代2), 大竹千晶2), 西村滋子1) Japanese Journal of Transfusion and Cell Therapy 62(2): 269-269, 2016. |
|---|
|
|
Significance of the monitor management at the O-15 self blood sampling 田中朝志1), 鎌倉丈紘2), 嘉成孝志2), 関戸啓子2), 鈴木実2), 伊藤利一2), 福武勝幸3) Japanese Journal of Transfusion and Cell Therapy 62(2): 270-270, 2016. |
|---|
|
|
Incidence and risk factor of the delayed-action side effect to occur after self-blood drawing blood in the O-16 our hospital 鈴木啓二朗1), 小田原聖2), 高舘潤子2), 佐々木さき子2), 後藤健治2), 諏訪部章1) Japanese Journal of Transfusion and Cell Therapy 62(2): 270-270, 2016. |
|---|
|
|
Acceptance delivery guidelines making about the pregnant woman self blood with the O-17 neighborhood institution 織田のぞみ1),3), 中嶋ゆう子1),3), 山中浩代1),2), 雨宮憲彦3), 井上克枝3), 金子誠1) Japanese Journal of Transfusion and Cell Therapy 62(2): 271-271, 2016. |
|---|
|
|
Two cases of the myeloma that succeeded for peripheral blood stem cell sampling by stem cell mobilization by the combination of O-18 G-CSF and Plerixafor 壹岐聖子1), 木間夕子1), 銅島いずみ1), 昆雅士1), 阿部有2), 塚田信弘2) Japanese Journal of Transfusion and Cell Therapy 62(2): 271-271, 2016. |
|---|
|
|
PBSCH under the plerixafor combination for poor mobilizer of the O-19 multiple myeloma 芹澤憲太郎1), 森田泰慶1), 口分田貴裕1), 田中宏和1), 山田枝里佳2), 芦田隆司1),2), 松村到1) Japanese Journal of Transfusion and Cell Therapy 62(2): 272-272, 2016. |
|---|
|
|
O-20 Clinical impact of rituximab treatment for 3 patients with TTP at a single institution 河野徳明, 栗山拓郎, 山下清 Japanese Journal of Transfusion and Cell Therapy 62(2): 272-272, 2016. |
|---|
|
|
Difference between O-21 inborn character-related factor V deficiency and acquired factor V inhibitor for transfusion 平安山知子, 岩崎浩己, 國崎祐哉, 野波篤, 竹中克斗, 赤司浩一 Japanese Journal of Transfusion and Cell Therapy 62(2): 273-273, 2016. |
|---|
|
|
α2-anti-plasmin as the O-22 bleeding tendency predictor 内場光浩, 米村雄士, 松井啓隆 Japanese Journal of Transfusion and Cell Therapy 62(2): 273-273, 2016. |
|---|
|
|
One case of the TMA which we were complicated with acute renal failure, heart failure, pancreatitis all over the O-23 course, and unrepresentativeness haemolytic uraemic syndrome was suspected in 経田克則 Japanese Journal of Transfusion and Cell Therapy 62(2): 274-274, 2016. |
|---|
|
|
The long-term natural history and glycosylation type subfraction ratio of the high ferritin blood symptom prolonged after a breakaway from O-24 erythrocyte transfusion dependence 堀池重夫1),2), 水谷信介2), 志村勇司2), 松本洋典2), 住田由香理1), 森教子1), 井上寛之1), 小森浩美1), 笹田裕司1), 稲葉亨1), 谷脇雅史2) Japanese Journal of Transfusion and Cell Therapy 62(2): 274-274, 2016. |
|---|
|
|
Introduction of modified ascitic filtration concentration re-IV infusion law (KM-CART) in the O-25 transfusion section 阿出川裕子1), 大竹龍三郎1), 笠根萌美1), 中林咲織1), 高橋典子1), 吉田茂久3), 田野崎隆二2) Japanese Journal of Transfusion and Cell Therapy 62(2): 275-275, 2016. |
|---|
|
|
About the construction of the urgent transfusion system in the O-26 our hospital and a future problem 得能寛子3), 前田結香1), 高橋明子1), 井手洋昭1), 藤島充弘1), 梅木智美3), 鷹野壽代2) Japanese Journal of Transfusion and Cell Therapy 62(2): 275-275, 2016. |
|---|
|
|
The request situation of the urgent transfusion of our hospital for patients with O-27 serious case injury 楠本壽子, 吉田昌弘, 山内容子, 濱田充生 Japanese Journal of Transfusion and Cell Therapy 62(2): 276-276, 2016. |
|---|
|
|
Evaluation of the use of blood clotting factor IX complex for the urgent bleeding of the O-28 anticoagulation patients 田中和秀1),2), 臼田直美1), 下村真由4), 稲川千恵4), 中永徳子4), 廣瀬五十子4), 笠原千嗣3), 高橋健1) Japanese Journal of Transfusion and Cell Therapy 62(2): 276-276, 2016. |
|---|
|
|
About operation of the ABO same model cryoprecipitate in the O-29 our hospital and the use situation 大塚浩平, 河原好絵, 高橋裕之, 渡辺直樹, 花田大輔, 友田豊, 藤井聡 Japanese Journal of Transfusion and Cell Therapy 62(2): 277-277, 2016. |
|---|
|
|
The use of de-Clio results for the obstetrics and gynecology department massive bleeding in the O-30 our hospital 村山和子, 宮崎研一 Japanese Journal of Transfusion and Cell Therapy 62(2): 277-277, 2016. |
|---|
|
|
O-31 Study of ABO blood type front and back test mismatch cases except for hematopoietic stem cell transplantation after the cases in our hospital 川俣豊隆1), 衡田経子2), 阿部結花2), 長村登紀子2) Japanese Journal of Transfusion and Cell Therapy 62(2): 278-278, 2016. |
|---|
|
|
About the results and the usefulness of the genetic analysis in the O-32 ABO blood group subtype 道野淳子1), 安村敏1), 富山隆介1), 中出祥代1), 佐竹伊津子1), 島京子1), 在田幸太郎2), 和田暁法2), 村上純2), 北島勲1) Japanese Journal of Transfusion and Cell Therapy 62(2): 278-278, 2016. |
|---|
|
|
Example that racked its brains about a blood grouping in acknowledgment of O-33 A-antigen attenuation 渡邊由香理1), 志磨美緒1), 小松美保1), 鴨川康代1), 平松潔子1), 南有美子1), 小田晃2), 木村恵子2), 河野武弘1) Japanese Journal of Transfusion and Cell Therapy 62(2): 279-279, 2016. |
|---|
|
|
Usefulness of the partial cohesion red blood cell analysis using O-34 CELL-DYN SAPPHIRE 笠井大助1), 高橋一三2) Japanese Journal of Transfusion and Cell Therapy 62(2): 279-279, 2016. |
|---|
|
|
Screening of the irregular antibody for the low frequency antigen using O-35 FCM 宮崎孔1), 大橋恒1), 松林圭二1), 佐藤進一郎1), 加藤俊明1), 池田久實2), 紀野修一1), 山本哲2), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 280-280, 2016. |
|---|
|
|
About the case that antiD production with the O-36 Del erythrocyte transfusion was reported 川畑絹代1), 安田広康2),3), 内川誠4), 大戸斉1) Japanese Journal of Transfusion and Cell Therapy 62(2): 280-280, 2016. |
|---|
|
|
One case that a blood corpuscle derived from children was not detected after the fetal blood transfusion that we gave for O-37 RhD blood type incompatibility 青木香苗1), 榎本麻里1), 池松陽子1), 山口恭子1), 平安山知子2), 岩崎浩己2), 赤司浩一2) Japanese Journal of Transfusion and Cell Therapy 62(2): 281-281, 2016. |
|---|
|
|
The case that came to have difficulty in postnatal blood grouping by O-38 twin to twin transfusion syndrome and fetal blood transfusion 福岡玲1), 饗庭桂子2), 大野里美2), 山田俊樹3) Japanese Journal of Transfusion and Cell Therapy 62(2): 281-281, 2016. |
|---|
|
|
Change of antiA antiB antibody titers in the O-39 ABO main mismatch liver, the kidney transplantation 小林美佳, 秋山友子, 大槻郁子, 進藤聖子, 尾島佐恵子, 小幡隆, 小野崎文子, 中木陽子, 菅野直子, 岸野光司, 岡塚貴世志, 室井一男 Japanese Journal of Transfusion and Cell Therapy 62(2): 282-282, 2016. |
|---|
|
|
Expression of cell membrane surface carbohydrate chain change in the O-40 Swirling-negative platelet 小池敏靖, 森純平, 寺田あかね, 林智也, 岩本澄清, 沖学, 藤村吉博 Japanese Journal of Transfusion and Cell Therapy 62(2): 282-282, 2016. |
|---|
|
|
About the effect that storage time and storage temperature of the O-41 whole blood liquid give to clot organization potency of the plasma 布施久恵1), 藤原満博1), 若本志乃舞1), 内藤祐1), 林宜亨1), 秋野光明2), 小野寺秀一3), 茶谷真3), 栗原勝彦3), 柴雅之4), 本間稚広1), 山本哲5), 池田久實5), 紀野修一1), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 283-283, 2016. |
|---|
|
|
Suggestion from O-42 high school student to the blood donation promotion 芝田大樹1), 藤原晴美1), 保坂侑里1), 榛葉隆人1), 都築茉里子1), 石塚恵子1), 古牧宏啓1), 山田千亜希1), 渡邊弘子1), 金子誠1), 室井一男2), 竹下明裕1) Japanese Journal of Transfusion and Cell Therapy 62(2): 283-283, 2016. |
|---|
|
|
It is a comparison before and after becoming it the collection in use - district hospital in the expiration date of O-43 blood products 九里孝雄1),2), 鈴木久仁子1), 藤田沙耶花1), 樫村誠2) Japanese Journal of Transfusion and Cell Therapy 62(2): 284-284, 2016. |
|---|
|
|
Promotion of the proper use by the uniform management of the plasma derivative except the O-44 albumin preparation 古牧宏啓, 山田千亜希, 芝田大樹, 石塚恵子, 榛葉隆人, 保坂侑里, 都築茉里子, 藤原晴美, 渡邊弘子, 金子誠, 竹下明裕 Japanese Journal of Transfusion and Cell Therapy 62(2): 284-284, 2016. |
|---|
|
|
Use fact-finding of the albumin preparation in the O-45 senior Pope 山崎尚也, 藤井輝久, 齋藤誠司, 栗田絵美, 河野真由, 小松真由美, 野間慎尋, 平岡朝子, 廣瀬祥子, 山岡愛子, 平野洋子 Japanese Journal of Transfusion and Cell Therapy 62(2): 285-285, 2016. |
|---|
|
|
Efforts for the O-46 albumin preparation consumption reduction 山川朋世1), 篠原茂1), 高柳玲子1), 池田紀彦1), 簗瀬直樹1), 及川信次1),2), 神部智子3), 高橋渉1),4), 三谷絹子1),4) Japanese Journal of Transfusion and Cell Therapy 62(2): 285-285, 2016. |
|---|
|
|
Problem to the consciousness of the patients for the country of origin of the O-47 albumin preparation and the physician and domestic self-support 坂倉慶太1),3), 新井さゆみ1),3), 丸橋隆行2),3), 林泰秀1),3), 横濱章彦2),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 286-286, 2016. |
|---|
|
|
Role of the transfusion section to carry out for promotion of the appropriate transfusion by the introduction of the rapid test in the O-48 technique 山田千亜希, 藤原晴美, 渡邊弘子, 金子誠, 芝田大樹, 古牧宏啓, 石塚恵子, 都築茉里子, 榛葉隆人, 保坂侑里, 竹下明裕 Japanese Journal of Transfusion and Cell Therapy 62(2): 286-286, 2016. |
|---|
|
|
Examination about the transfusion preparations system at brain death liver transplantation in the O-49 our hospital and the consumption 上床貴代, 渡邊千秋, 伊藤誠, 米岡麻記, 重松明男, 加畑馨, 清水力 Japanese Journal of Transfusion and Cell Therapy 62(2): 287-287, 2016. |
|---|
|
|
The present conditions of the perioperative erythrocyte transfusion in the O-50 our hospital 遠藤一幸1), 内山詩織1), 竹生智美1), 杉野智広1), 原嘉子1), 松岡牧1), 浅野千尋1),2), 増田道彦1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 287-287, 2016. |
|---|
|
|
Efforts (individual case inspection and department visit inspection) of the adequacy of the transfusion therapy with the transfusion inspection system of O-51 two 青島敬二, 山岸弥生 Japanese Journal of Transfusion and Cell Therapy 62(2): 288-288, 2016. |
|---|
|
|
Inspection about HBs antibody standard 200mIU/mL in the screening of the blood for the O-52 transfusion 星友二, 山岸尚仁, 長谷川隆, 安藤菜穂子, 遠田静穂, 五反田裕子, 内田茂治, 永井正, 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 62(2): 288-288, 2016. |
|---|
|
|
Collaborative investigation for reevaluations of the titer of the O-53 HBV-DNA country reference standard 水澤左衛子1), 山口照英2), 浜口功1) Japanese Journal of Transfusion and Cell Therapy 62(2): 289-289, 2016. |
|---|
|
|
About the posttransfusion HBV infection that led to early treatment by an examination of infection after O-54 transfusion 多原好江1), 前橋美智子1), 鈴木由美子1), 浅井隆善1), 平力造2), 遠田静穂3), 村澤利延4), 丹麻美4) Japanese Journal of Transfusion and Cell Therapy 62(2): 289-289, 2016. |
|---|
|
|
Count and consideration (HBV, HCV, HIV) of the blood receiver information obtained by retrospective search to affect a change into positive example of the O-55 multiple volunteer blood donor 廣井和雄, 平力造 Japanese Journal of Transfusion and Cell Therapy 62(2): 290-290, 2016. |
|---|
|
|
HCV genotype distribution in the O-56 HCV antibody-positive /HCV-NAT-positive volunteer blood donor 宮川恵子, 高倉明子, 五反田裕子, 内田茂治, 永井正, 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 62(2): 290-290, 2016. |
|---|
|
|
Hepatitis E virus infection case caused by the O-57 transfusion 須佐梢1), 丸橋隆行1), 西本奈津美1), 石川怜依奈1), 関上智美1), 三井健揮2), 横濱章彦1) Japanese Journal of Transfusion and Cell Therapy 62(2): 291-291, 2016. |
|---|
|
|
Analysis of the SNP in the FCGR3A gene influencing ADCC activity and CD16 receptor expression of natural killer cell in the O-58 Japanese group 大星航1),3), 多田智紀1), 安藝健作2), 細井英司2) Japanese Journal of Transfusion and Cell Therapy 62(2): 291-291, 2016. |
|---|
|
|
O-59 Circulating MAIT cells are decreased in subjects with multiple cardiovascular risk factors 藤井聡, 赤坂和美, 高橋裕之, 河原好絵, 渡辺直樹, 大塚浩平, 友田豊 Japanese Journal of Transfusion and Cell Therapy 62(2): 292-292, 2016. |
|---|
|
|
O-60 Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions. 中山享之1), 西脇聡史2), 村田誠3), 西田徹也3), 加藤栄史1) Japanese Journal of Transfusion and Cell Therapy 62(2): 292-292, 2016. |
|---|
|
|
Relative examination with the treatment effect of O-61 immunity checkpoint molecules and the dendritic cells opsonic therapy 湯沢美紀1), 樋口由美子1), 小屋照継1), 山岡直子1), 水野由美子1), 石川伸介1), 堀内香与2), 吉江恵2), 平林耕一1), 小林孝至1), 下平滋隆1) Japanese Journal of Transfusion and Cell Therapy 62(2): 293-293, 2016. |
|---|
|
|
An instruction of the antigen-specific T cell with the O-62 dendritic cells therapy and relative examination with the disease 水野由美子1), 樋口由美子1), 小屋照継1), 湯沢美紀1), 山岡直子1), 石川伸介1), 堀内香与2), 吉江恵2), 平林耕一1), 小林孝至1), 下平滋隆1) Japanese Journal of Transfusion and Cell Therapy 62(2): 293-293, 2016. |
|---|
|
|
Basic study on repetition freeze, culture increase law of mesenchymal cells derived from person from O-63 adipose tissue 隅田幸男 Japanese Journal of Transfusion and Cell Therapy 62(2): 294-294, 2016. |
|---|
|
|
Development of the plasma origin antiHTLV-1 human immunoglobulin preparation aiming at prevention of O-64 HTLV-1 infection 野島清子1), 水上拓郎1), 松本千惠子2), 蕎麦田理英子2), 佐竹正博2), 大隈和1), 手塚健太1), 倉光球1), 荒木久美子1), 山口一成1), 浜口功1) Japanese Journal of Transfusion and Cell Therapy 62(2): 294-294, 2016. |
|---|
|
|
Comparison between mother's milk and professional viral load in the peripheral blood and possession antibody of O-65 HTLV-1 carrier mother 井上由紀子1), 守田麻衣子1), 相良康子1), 後藤信代1), 迫田岩根1), 入田和男1),2), 清川博之1) Japanese Journal of Transfusion and Cell Therapy 62(2): 295-295, 2016. |
|---|
|
|
Development of the high sensitivity simultaneous test for the detection of the dengue virus 4 serotype by O-66 Multiplex RT-qPCR 手塚健太1), 倉光球1), 大隈和1), 野島清子1), 荒木久美子1), 篠原直也2), 松本千惠子2), 佐竹正博2), 浜口功1) Japanese Journal of Transfusion and Cell Therapy 62(2): 295-295, 2016. |
|---|
|
|
Study on inactivation of the Leishmania protozoan by a storage temperature and the leukopheresis of blood products for the O-67 transfusion and removal effect 岡田義昭, 小林清子, 池淵研二 Japanese Journal of Transfusion and Cell Therapy 62(2): 296-296, 2016. |
|---|
|
|
Mainly on change - leukopheresis filter of Trypanosoma cruzi (Chagas' disease protozoan) in blood products for the O-68 transfusion and red blood cell preparation - 佐山勇輔, 松本千惠子, 山岸尚仁, 内田茂治, 永井正, 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 62(2): 296-296, 2016. |
|---|
|
|
It is the virus infection in the patients after O-69 same kind hematopoietic stem cell transplantation 吉岡佑里子1), 松本真弓2), 常峰紘子3), 小高泰一3) Japanese Journal of Transfusion and Cell Therapy 62(2): 297-297, 2016. |
|---|
|
|
β herpesvirus of suspected GVHD and GVHD case patients plasma after O-70 transfusion 松本千惠子1), 渡辺嘉久1), 蕎麦田理英子1), 内田茂治1), 永井正1), 佐竹正博1), 田所憲治2) Japanese Journal of Transfusion and Cell Therapy 62(2): 297-297, 2016. |
|---|
|
|
Examination of the MRD analysis in the O-71 periphery hematopoietic stem cells apheresis 冨岡美咲1), 熊坂肇1), 鈴木香子1), 竹内正美2) Japanese Journal of Transfusion and Cell Therapy 62(2): 298-298, 2016. |
|---|
|
|
Multicenter prospective study about the O-72 peripheral blood hematopoietic stem cells sampling: Spectra-Auto vs. Spectra-Optia (the third report) 藤原慎一郎1), 池田和彦2),7), 皆川敬治2), 室井一男1),3),7), 藤原実名美4), 藤盛好啓5),7), 田野崎隆二6),7), 大戸斉2),7) Japanese Journal of Transfusion and Cell Therapy 62(2): 298-298, 2016. |
|---|
|
|
Use experience of Spectra and the Optia 2 mode in the O-73 our hospital 伊藤誠1), 加畑馨1),2), 渡邊千秋1), 上床貴代1), 米岡麻記1), 小杉瑞葉1),2), 重松明男1),2), 高橋正二郎1),2), 杉田純一2), 橋本大吾2), 佐藤典宏3), 豊嶋崇徳2), 清水力1) Japanese Journal of Transfusion and Cell Therapy 62(2): 299-299, 2016. |
|---|
|
|
We look at the rear about the marrow concentration method using blood component separation device COBE Spectra in the O-74 our hospital and analyze a mark 酒井紫緒1),2), 三村尚也1),2), 猪越ひろむ1), 押尾知子1), 長谷川浩子1), 山本浩子1), 伊藤道博1), 中世古知昭2), 井関徹1) Japanese Journal of Transfusion and Cell Therapy 62(2): 299-299, 2016. |
|---|
|
|
As compared with performance evaluation - COBE(R) Spectra AUTO mode of O-75 Optia(R) (Terumo BCT) ... 比毛稔1), 和氣敦2), 牧野茂義3) Japanese Journal of Transfusion and Cell Therapy 62(2): 300-300, 2016. |
|---|
|
|
About problems after the plasma derivative uniform management - second report start in the O-76 Aichi Medical University Hospital and the correspondence - 丹羽玲子, 藤田江美, 石山和樹, 松尾友仁, 清水彩, 高四強, 安藤高宣, 林恵美, 片井明子, 高橋美裕希, 中山享之, 加藤栄史 Japanese Journal of Transfusion and Cell Therapy 62(2): 300-300, 2016. |
|---|
|
|
Examination of the use situation of division blood products in the O-77 Okayama University Hospital 池田亮1), 小郷博昭1), 高木尚江2), 浅野尚美1), 小林優人1),3), 藤井敬子3),4), 藤井伸治1),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 301-301, 2016. |
|---|
|
|
Analysis of the plasma exchange in the O-78 our hospital for the past 5 years 大滝紘平, 藤川潤, 宮内万知子, 小田嶋康雄 Japanese Journal of Transfusion and Cell Therapy 62(2): 301-301, 2016. |
|---|
|
|
How should you do it to realize safe interhospital conveyance of interhospital one - self stem cell and self blood which we conveyed about O-79 cryopreservation self peripheral blood stem cell? 正本庸介1),3), 池田敏之1), 牧野茂義2), 牧宏彰1),3), 伊井野潤子1), 川端みちる1), 岡崎仁1) Japanese Journal of Transfusion and Cell Therapy 62(2): 302-302, 2016. |
|---|
|
|
The use situation of blood products in the lung transplantation in the O-80 Kyoto Univ. Hospital 丹羽紀実, 平位秀世, 万木紀美子, 菱田理恵, 山下史乃, 三浦康生, 前川平 Japanese Journal of Transfusion and Cell Therapy 62(2): 302-302, 2016. |
|---|
|
|
Collaborative progress about the red blood cell preparation transfusion for O-81 irregularity antibody-positive patients 山田千亜希1),10), 田所憲治2),10), 渡邊弘子1),10), 原口安江3),10), 阿部操4),10), 祖父江晃基5),10), 佐々木さき子6),10), 杉本達哉7),10), 野間口由利子8),10), 道野淳子9),10), 石丸健2),10), 宮城徹2),10), 竹下明裕1),10) Japanese Journal of Transfusion and Cell Therapy 62(2): 303-303, 2016. |
|---|
|
|
Multicenter study on childhood alloimmunity for the O-82 erythrocyte antigen 玉井佳子1), 大戸斉2), 北澤淳一3),7), 立花直樹3),7), 藤島直仁4), 藤原実名美5), 東寛7), 小川千登世7), 小原明7), 梶原道子7), 小山典久7), 細野茂春7), 堀越泰雄7), 伊藤悦朗1),6) Japanese Journal of Transfusion and Cell Therapy 62(2): 303-303, 2016. |
|---|
|
|
About the holding of the workshop to affect the handling of blood products for the transfusion for nurses by the O-83 blood center 内藤一憲, 杉原珠子, 小島麻美, 牧野志保, 小川峰津江, 石井乃生子, 青井あゆみ, 松本喜久代, 奥裕美, 高見正恵, 片岡由佳, 為本朋子, 冨田徳子, 池田和眞 Japanese Journal of Transfusion and Cell Therapy 62(2): 304-304, 2016. |
|---|
|
|
The urgent supply system of blood products for the transfusion in the relief plan medical at an O-84 Kochi disaster 溝渕樹, 濱田秀誠, 北川晋士, 関文, 吉門早苗, 藤原弓子, 木村勝 Japanese Journal of Transfusion and Cell Therapy 62(2): 304-304, 2016. |
|---|
|
|
Focus on blood management and the enforcement system and the transfusion out of use of blood products fact-finding report ... hospital in O-85 2014; and ... 北澤淳一1),2), 田中朝志3), 牧野茂義4), 菅野仁5), 高橋孝喜6), 半田誠7) Japanese Journal of Transfusion and Cell Therapy 62(2): 305-305, 2016. |
|---|
|
|
Focus on blood management and enforcement system and use of blood products fact-finding report - foreign transfusion in O-86 2014; and ... 北澤淳一1),2), 田中朝志3), 牧野茂義4), 菅野仁5), 高橋孝喜6), 半田誠7) Japanese Journal of Transfusion and Cell Therapy 62(2): 305-305, 2016. |
|---|
|
|
Recent efforts of Tokyo for the O-87 transfusion proper use 藤田浩 Japanese Journal of Transfusion and Cell Therapy 62(2): 306-306, 2016. |
|---|
|
|
Development of the cyclopedic diagnostic method of Coombs negative autoimmune haemolytic anaemias using O-88 column method direct Coombs test 亀崎豊実 Japanese Journal of Transfusion and Cell Therapy 62(2): 306-306, 2016. |
|---|
|
|
Comparison between technique and examination of irregular antibody screening with the automatic transfusion inspection equipment (solid phase methods) for O-89 (the third report) 安部舞衣子, 小野貴子, 川畑絹代, 小野智, 菊地正美, 菅原亜紀子, 斎藤俊一, 曳地理絵, 高野希美, 皆川敬治, 鈴木裕恵, 渡邉万央, 奥津美穂, 安田広康, 大戸斉 Japanese Journal of Transfusion and Cell Therapy 62(2): 307-307, 2016. |
|---|
|
|
About the clinical significance of the irregular antibody in response to only O-90 enzyme method 関戸啓子1), 鎌倉丈紘1), 嘉成孝志1), 鈴木実1), 伊藤利一1), 田中朝志2) Japanese Journal of Transfusion and Cell Therapy 62(2): 307-307, 2016. |
|---|
|
|
Safe examination in computer cross match 11 years when the validity of the O-91 irregularity test for antibodies was two weeks 越智千晶1), 土居靖和1), 高野須広道1), 秋田誠1), 西宮達也2), 谷口裕美2), 羽藤高明1) Japanese Journal of Transfusion and Cell Therapy 62(2): 308-308, 2016. |
|---|
|
|
Report of the enforcement situation and the detection antibody of the irregular test for antibodies of the O-92 pregnant woman 岡本彩1), 大島恵子1), 吉田健一1), 川上麻里絵1), 中村拓路1),2), 正木康史1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 308-308, 2016. |
|---|
|
|
The case that caused blood transfusion reaction by the O-93 37 degrees Celsius /60min Coombes method in negative antiM 渡辺隆幸1), 神山龍之介1), 星雅子1), 大澤裕美1), 橋本はるみ1), 石井佳代子1), 神林裕行1),2), 大知里京子3), 作間靖子3) Japanese Journal of Transfusion and Cell Therapy 62(2): 309-309, 2016. |
|---|
|
|
2 cases that became the transfusion with incompatible blood by an irregular antibody at O-94 emergency transfusion 関恵美1), 結城孝子1), 佐藤まゆみ1), 池邉太一2) Japanese Journal of Transfusion and Cell Therapy 62(2): 309-309, 2016. |
|---|
|
|
An example who had the acute adverse event that is hemolytic posttransfusion by mechanism except the O-95 blood group antibodies 高梨丈治1), 田近賢二2), 横田晶子1), 原優子1), 五味聖二3), 佐久間初代1) Japanese Journal of Transfusion and Cell Therapy 62(2): 310-310, 2016. |
|---|
|
|
Increase of the quantity of red blood cell Jra antigen due to the O-96 ABCG2 mutation in the gene 長部隆広1), 海透紗弥佳1), 伊佐和美2), 佐々木佳奈2), 小笠原健一2), 矢部隆一1), 大村和代1), 内川誠1), 鈴木雅治1), 中島一格1) Japanese Journal of Transfusion and Cell Therapy 62(2): 310-310, 2016. |
|---|
|
|
Examination about the mutation in the gene of an O-97 Jr(a-) type and the Jr(a+w) type and the serologic reactivity 荻山佳子1), 伊藤正一1), 入野美千代1), 鈴木光1), 峯岸正好1), 清水博1), 長部隆広2), 伊佐和美3), 小笠原健一3) Japanese Journal of Transfusion and Cell Therapy 62(2): 311-311, 2016. |
|---|
|
|
Expression of Jra antigen analysis in O-98 erythroid progenitor cells 内村大祐1), 宮崎孔1), 大橋恒1), 松林圭二1), 佐藤進一郎1), 加藤俊明1), 池田久實2), 紀野修一1), 山本哲2), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 311-311, 2016. |
|---|
|
|
JK gene of the Jka antigen indicating the response that O-99 is vulnerable to and the Jkb antigen 伊佐和美1), 小笠原健一1), 小野寺孝行2), 海透紗弥佳2), 長部隆広2), 豊田智津2), 鈴木由美2), 矢部隆一2), 常山初江2), 内川誠2), 永井正1), 佐竹正博1) Japanese Journal of Transfusion and Cell Therapy 62(2): 312-312, 2016. |
|---|
|
|
About the judgment of the Bm type by the genetic analysis using the PCR-SSP method for the deletion of O-100 two kinds 前島理恵子1),2), 藤原孝記1), 冨山秀和1), 金子強1), 永友ひとみ1), 蟹井はるか1), 笠井英利1), 難波宏美1), 大曽根和子1), 灰野夏澄1), 松本謙介1),2), 白藤尚毅1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 312-312, 2016. |
|---|
|
|
Effect on mechanism and protein expression of Exxon skipping causing O-101 WeakD/Del 三島由祐子1), 池田敏之1), 佐藤智彦1),2), 正本庸介1), 名倉豊1), 曽根伸治1), 岡崎仁1) Japanese Journal of Transfusion and Cell Therapy 62(2): 313-313, 2016. |
|---|
|
|
Protease-resistant M antigen with O-102 GP(E-B) high Bullitt molecules 常山初江1), 大河内直子1), 伊佐和美2), 小笠原健一2), 山口陽平1), 矢部隆一1), 内川誠1), 鈴木雅治1), 中島一格1) Japanese Journal of Transfusion and Cell Therapy 62(2): 313-313, 2016. |
|---|
|
|
Manufacture of O-103 IgG subclass steady regional recombinant antiD 飛田隆太郎, 青山奈央, 海透紗弥佳, 鈴木由美, 豊田智津, 矢部隆一, 大村和代, 内川誠, 鈴木雅治, 中島一格 Japanese Journal of Transfusion and Cell Therapy 62(2): 314-314, 2016. |
|---|
|
|
It is effect measurement ... after an examination of infection, the transfusion after ... transfusion about efforts of the transfusion duties improvement in the O-104 our hospital 石田智子1), 岩下洋一1), 荒川航太1), 佐藤俊哉1), 蓮沼秀和1), 清水直美2) Japanese Journal of Transfusion and Cell Therapy 62(2): 314-314, 2016. |
|---|
|
|
Simple and easy efficiency ... of efforts - blood transfusion reaction record system for the construction of the O-105 blood transfusion reaction surveillance system 中嶋ゆう子1),2), 織田のぞみ1),2), 山中浩代1),3), 雨宮憲彦2), 井上克枝2), 金子誠1) Japanese Journal of Transfusion and Cell Therapy 62(2): 315-315, 2016. |
|---|
|
|
Efforts for rate of use improvement of the examination of O-106 posttransfusion infection 平安山良彦, 舩石理絵, 鈴木重徳, 塩之入千恵子 Japanese Journal of Transfusion and Cell Therapy 62(2): 315-315, 2016. |
|---|
|
|
Look back on the efforts of O-107 inside the hospital inspection three and a half years 山本麻貴1), 飛田規2), 藤澤紳哉3), 佐藤政季1), 水野達也4) Japanese Journal of Transfusion and Cell Therapy 62(2): 316-316, 2016. |
|---|
|
|
The early administration of fibrinogen preparation for patients with O-108 serious case injury contributes to a drop of the mortality! 山本晃士1), 山口充2), 阿南昌弘1), 大木浩子1), 井口浩一2), 澤野誠2) Japanese Journal of Transfusion and Cell Therapy 62(2): 316-316, 2016. |
|---|
|
|
About the use experience of the O-109 Clio seal system (self-fibrin paste) 三浦邦彦1), 島谷佳織1), 中静久美1), 安保義恭2) Japanese Journal of Transfusion and Cell Therapy 62(2): 317-317, 2016. |
|---|
|
|
Effect of the cryoprecipitate on multiple injuries in the O-110 our hospital 杉山和宏1), 西村滋子2), 高田裕子3), 五十嵐朋子3), 浅香祐幸3), 中原美千代3), 大竹千晶3), 藤田浩2) Japanese Journal of Transfusion and Cell Therapy 62(2): 317-317, 2016. |
|---|
|
|
Clinical benefit of the cryoprecipitate for the obstetric disease in the O-111 our hospital 高田裕子1), 五十嵐朋子1), 浅香祐幸1), 中原美千代1), 大竹千晶1), 西村滋子2), 藤田浩2) Japanese Journal of Transfusion and Cell Therapy 62(2): 318-318, 2016. |
|---|
|
|
O-112 For Fib amount verification in creopresipitate formulation in our hospital 山路直人1),2), 森恵子1),2), 大西まり1),3), 森尾志保1),3), 塩谷拓也1),4), 柴崎哲典1),4), 玉木茂久1),4) Japanese Journal of Transfusion and Cell Therapy 62(2): 318-318, 2016. |
|---|
|
|
Evaluation of the use situation and the transfusion effect of the O-113 cryoprecipitate 坂元あい子, 小山田栄子, 竹ノ内博之, 久冨木庸子, 下田和哉 Japanese Journal of Transfusion and Cell Therapy 62(2): 319-319, 2016. |
|---|
|
|
Advantageous effect to cord-blood transplant results of the O-114 HLA-DPB1 seat mismatch 屋部登志雄1),3), 東史啓1),3), 柏瀬貢一1),3), 松本加代子3), 折原武3), 矢部普正3), 小川篤子1),3), 甲斐俊朗3), 清川博之3), 森島聡子3), 加藤俊一3), 大村和代1), 鈴木雅治1), 高梨美乃子2),3), 佐竹正博2),3), 森島泰雄3), 中島一格1) Japanese Journal of Transfusion and Cell Therapy 62(2): 319-319, 2016. |
|---|
|
|
HLA new allyl confirmed by HLA typing by sequencer (NGS) in the O-115 next generation 宮崎有紀, 小島裕人, 田中秀則 Japanese Journal of Transfusion and Cell Therapy 62(2): 320-320, 2016. |
|---|
|
|
A frequency investigation of the O-116 humans platelet antigen and discovery of the new mutation in the gene 林智也, 石井博之, 高陽淑, 保井一太, 田中光信, 古田里佳, 高橋順子, 松倉晴道, 平山文也, 谷慶彦, 藤村吉博 Japanese Journal of Transfusion and Cell Therapy 62(2): 320-320, 2016. |
|---|
|
|
One case that produced new HLA antigens with the frequent transfusion during neonates same kind immune thrombocytopenia (NAIT) treatment with maternal antibody derived from O-117 mother 浜之上聡1), 小林洋紀2), 柏瀬貢一2) Japanese Journal of Transfusion and Cell Therapy 62(2): 321-321, 2016. |
|---|
|
|
It is undergone a change of the pregnant HPA antibody of the fourth child by the second-born child in the O-118 NAIT case (first-born child): Spontaneous drop in the late pregnancy of HPA 4b antibody titers 清川知子, 中山小太郎純友, 細川美香, 櫻木美基子, 森川珠世, 中尾まゆみ, 青地寛, 永峰啓丞, 味村和哉, 木村正, 冨山佳昭 Japanese Journal of Transfusion and Cell Therapy 62(2): 321-321, 2016. |
|---|
|
|
Analysis of the antiHLA antigens in the O-119 heart transplant case 伊井野潤子1), 松橋美佳2), 川端みちる1), 三島由祐子1), 曽根伸治1), 正本庸介1), 池田敏之1), 岡崎仁1) Japanese Journal of Transfusion and Cell Therapy 62(2): 322-322, 2016. |
|---|
|
|
One case that donor-specific HLA antigens (DSA) became positive by O-120 FFP transfusion, and postponed living renal transplantation 入江玲子, 池本純子, 杉山寛貴, 中西由紀, 大塚真哉, 小野本仁美, 前田和宏, 村田理恵, 藤田典子, 吉原哲, 藤盛好啓 Japanese Journal of Transfusion and Cell Therapy 62(2): 322-322, 2016. |
|---|
|
|
1 case of HLA antigens detected by O-121 red blood cell irregularity test for antibodies 李悦子, 小田直輝, 瀧本朋美, 仁木恵里加, 三木浩和, 安倍正博 Japanese Journal of Transfusion and Cell Therapy 62(2): 323-323, 2016. |
|---|
|
|
Examination about the HLA antigens which O-122 recipients of bone marrow transplant and the donor hold 菱田理恵1), 平位秀世1), 万木紀美子1), 丹羽紀実1), 竹川良子1), 三浦康生1), 前川平1), 菱澤方勝2), 近藤忠一2), 高折晃史2) Japanese Journal of Transfusion and Cell Therapy 62(2): 323-323, 2016. |
|---|
|
|
1 case that transfused the O-123 HPA-2a antibody possession patients with an antigen-positive platelet 岸友子1), 加藤亜有子2), 二部琴美3), 阿部和眞1), 岩渕佳那恵1), 及川一美1), 伊藤正一1), 鈴木光1), 峯岸正好1), 清水博1) Japanese Journal of Transfusion and Cell Therapy 62(2): 324-324, 2016. |
|---|
|
|
One patient whom it was supposed to be chimera in a platelet of the O-124 volunteer blood donor 山口惠津子1), 山崎久義1), 中村仁美1), 中村洋平1), 中山みゆき1), 黒田ゆかり1), 渡邉聖司1), 迫田岩根1), 入田和男1),2), 清川博之1) Japanese Journal of Transfusion and Cell Therapy 62(2): 324-324, 2016. |
|---|
|
|
Examination about the viable count rate of CD34-positive cells cryopreserved at -80 degrees Celsius by the O-125 simple freeze method 赤木智昭1), 玉井佳子2), 立花直樹3), 久保恒明1) Japanese Journal of Transfusion and Cell Therapy 62(2): 325-325, 2016. |
|---|
|
|
The clinical effect that processing of the peripheral blood hematopoietic stem cell transplantation graft performed between O-126 medical institutions and transportation duties give 長井一浩1), 原田浩1), 吉田真一郎2), 森内幸美3), 田口潤4), 宮崎泰司1),4) Japanese Journal of Transfusion and Cell Therapy 62(2): 325-325, 2016. |
|---|
|
|
It is comparison of the juvenile platelet ratio as the predictive marker of the platelet convalescence in the patients and the absolute value after O-127 hematopoietic stem cell transplantation 櫻木美基子1), 林悟2), 中山小太郎純友1), 細川美香1), 中尾まゆみ1), 森川珠世1), 清川知子1), 青地寛1), 永峰啓丞1), 藤田二郎2), 前田哲生2), 金倉譲2), 冨山佳昭1) Japanese Journal of Transfusion and Cell Therapy 62(2): 326-326, 2016. |
|---|
|
|
About the effect that nucleated cells (NC) concentrations in the O-128 self peripheral blood stem cell preservation give to a collect rate at thawing 小山暁史1), 杉本達哉1), 山口瞳1), 前沢由美子1), 櫻井朋美1), 中塩屋千絵1), 板垣浩行1), 武井美恵子1), 土田文子1), 扇屋大輔2), 村山広道2), 小林信昌1), 吉場史朗1) Japanese Journal of Transfusion and Cell Therapy 62(2): 326-326, 2016. |
|---|
|
|
Examination of the diachronic deterioration of the human platelet by the modified platelet blood period of retention assay using the O-129 rabbit 渡邊直英1), 野川誠之2), 江藤浩之3), 半田誠1) Japanese Journal of Transfusion and Cell Therapy 62(2): 327-327, 2016. |
|---|
|
|
Examination aiming at performance of the use of O-130 hollow thread membrane washing platelet manufacture, operability improvement 名倉豊1), 津野寛和1), 中村悠2), 岡崎仁1) Japanese Journal of Transfusion and Cell Therapy 62(2): 327-327, 2016. |
|---|
|
|
Change over time of the function with a property and the preservation of the platelet which we washed twice by O-131 automatic blood corpuscle washing device ACP215 林宜亨1), 若本志乃舞1), 布施久恵1), 藤原満博1), 遠藤正浩1), 本間稚広1), 山本哲2), 池田久實2), 紀野修一1), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 328-328, 2016. |
|---|
|
|
Usefulness of the washing platelet which manufactured inside the hospital using O-132 automatic platelet washing device 河野真由1), 平岡朝子1), 栗田絵美1), 野間慎尋1), 廣瀬祥子1), 山岡愛子1), 小松真由美1), 平野洋子3), 山崎尚也2), 齋藤誠司2), 藤井輝久2) Japanese Journal of Transfusion and Cell Therapy 62(2): 328-328, 2016. |
|---|
|
|
Examination about the twice washing of the platelet preparation using O-133 platelet stock solution BRS-A 遠藤希美加, 及川伸治, 星尚宏, 川島航, 鈴木光, 峯岸正好, 清水博 Japanese Journal of Transfusion and Cell Therapy 62(2): 329-329, 2016. |
|---|
|
|
Clinical response of the washing platelet which we prepared by O-134 stock solution BRS-A 及川伸治, 田口剛, 三浦正光, 遠藤希美加, 星尚宏, 川島航, 鈴木光, 峯岸正好, 清水博 Japanese Journal of Transfusion and Cell Therapy 62(2): 329-329, 2016. |
|---|
|
|
It is automatically washed the platelet preparation 20 unit using the O-135 bicarbonic acid Ringer's solution 佐久間直之, 遠藤希美加, 及川伸治, 川島航, 鈴木光, 峯岸正好, 清水博 Japanese Journal of Transfusion and Cell Therapy 62(2): 330-330, 2016. |
|---|
|
|
Efforts of society authorization, the clinical transfusion nurse for the standardization of the O-136 inside the hospital division preparation transfusion enforcement method 高尾真由美1), 渡邉理香2), 小島奈緒美2), 山本由美子2), 前田由香里2), 藤井康彦2) Japanese Journal of Transfusion and Cell Therapy 62(2): 330-330, 2016. |
|---|
|
|
In-hospital patrol results report in the O-137 transfusion Committee small working activity 山野靖子1), 阪口真紀1), 満馨1), 金佳江1), 鵜池純子1), 藤野惠三2), 松本有紀2), 武田真一2), 山口 (中上) 悦子3), 田守昭博2),4) Japanese Journal of Transfusion and Cell Therapy 62(2): 331-331, 2016. |
|---|
|
|
Blood transfusion reaction brochure making, operational effect on O-138 outpatient department transfusion patients 塗谷智子1), 相内宏美1), 工藤美代子1), 伴佳奈1), 二階愛理1), 佐藤ゆり子1), 中田陽子1), 三浦聡子1), 山崎喜子1), 須藤のり子1), 北川三千枝1), 久保章子1), 北澤淳一2), 立花直樹2) Japanese Journal of Transfusion and Cell Therapy 62(2): 331-331, 2016. |
|---|
|
|
Attitude survey for the side effect of the nurse before and after brochure making, the operation for O-139 outpatient department transfusion patients 相内宏美1), 塗谷智子1), 工藤美代子1), 伴佳奈1), 二階愛理1), 佐藤ゆり子1), 中田陽子1), 三浦聡子1), 山崎喜子1), 須藤のり子1), 北川三千枝1), 久保章子1), 北澤淳一2), 立花直樹2) Japanese Journal of Transfusion and Cell Therapy 62(2): 332-332, 2016. |
|---|
|
|
About the in-hospital team approach in medical care that O-140 transfusion section participated in 市井直美, 長谷川智子, 堀口新悟, 伊藤幸子, 石橋美由紀, 石井謙一郎, 山下香奈子, 岡田亜由美, 飛内英里, 影山有美子, 早川修司, 笠間絹代, 田崎哲典 Japanese Journal of Transfusion and Cell Therapy 62(2): 332-332, 2016. |
|---|
|
|
For profit management analysis - problems and the duties improvement using the transfusion duties profit management system which utilized O-141 transfusion section system - 福島靖幸, 岩本ちづる, 中野勝彦, 川野亜美, 山田枝里佳, 井手大輔, 前田岳宏, 菅野知恵美, 椿本祐子, 金光靖, 前川清, 芦田隆司 Japanese Journal of Transfusion and Cell Therapy 62(2): 333-333, 2016. |
|---|
|
|
The consecutive measurement of bloodstream at platelet blood donation using the O-142 laser rheometer and the number of the pulsation and approach to VVR foresight 高橋卓1), 山本哲1), 高本滋2), 紀野修一2) Japanese Journal of Transfusion and Cell Therapy 62(2): 333-333, 2016. |
|---|
|
|
Usefulness of the leukopheresis disposal of O-143 pregnant woman self blood before preservation 山中浩代1),2), 織田のぞみ2),3), 中嶋ゆう子2),3), 樋口浩二2), 雨宮憲彦3), 井上克枝3), 金子誠2) Japanese Journal of Transfusion and Cell Therapy 62(2): 334-334, 2016. |
|---|
|
|
The evaluation of the psychologic stress to occur at O-144 infants self blood drawing blood and examination of the relation to make consciousness for the uneasiness dispersed 塩崎暁子1), 柳沢龍2), 坂下一夫2), 小野貴子3), 立澤有香3), 下平滋隆4) Japanese Journal of Transfusion and Cell Therapy 62(2): 334-334, 2016. |
|---|
|
|
Look back on five years as the O-145 society authorized clinical transfusion nurse 今野マユミ1),2), 小出由美2), 岡本好雄1), 小野慎吾1), 松田和樹1), 久保田友晶1), 守屋友美1), 及川美幸1), 千野峰子1), 岡田真一1), 中林恭子1), 槍澤大樹1), 小林博人1), 菅野仁1) Japanese Journal of Transfusion and Cell Therapy 62(2): 335-335, 2016. |
|---|
|
|
Nurse transfusion duties investigation analysis report (the first report) in the O-146 Ogaki Municipal Hospital 伊藤裕子1), 田中典子1), 鳥居知美1), 三田村桂二1), 森美恵子2), 田中正子2), 平野美佳2), 傍島久美2), 堀井舞2), 井本直人3), 小杉浩史1),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 335-335, 2016. |
|---|
|
|
The present conditions and problem of the blood transfusion reaction in the P-1 Shonan Kamakura General Hospital 槇恭佑, 鈴木萌子, 三浦夢摘, 渡邉智美 Japanese Journal of Transfusion and Cell Therapy 62(2): 339-339, 2016. |
|---|
|
|
Blood transfusion reaction to be taking place in P-2 Hospital 上田真弘, 早川郁代, 橋本誠, 南陽介, 南博信 Japanese Journal of Transfusion and Cell Therapy 62(2): 339-339, 2016. |
|---|
|
|
One case of the transfusion-associated acute pulmonary disorder that occurred during P-3 platelet concentrate transfusion 川上麻里絵1), 大島恵子1), 吉田健一1), 岡本彩1), 中村拓路1),2), 正木康史1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 340-340, 2016. |
|---|
|
|
Basophils activation study (BAT) of the patients whom P-4 non-hemolysis blood transfusion reaction developed in 浅沼亜樹, 下山田高茂, 渡辺嘉久, 石川善英, 永井正, 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 62(2): 340-340, 2016. |
|---|
|
|
About the use situation of the nonhemolytic blood transfusion reaction and washing platelet in P-5 Akita 國井華子, 吉田斉, 寺田亨, 二部琴美, 鎌田博子, 阿部真, 面川進 Japanese Journal of Transfusion and Cell Therapy 62(2): 341-341, 2016. |
|---|
|
|
Examination of the patients background associated with the P-6 children transfusion allergic reaction 柳沢龍1), 坂下一夫1), 小野貴子2), 立澤有香2), 下平滋隆3),4) Japanese Journal of Transfusion and Cell Therapy 62(2): 341-341, 2016. |
|---|
|
|
One case of the transfusion-associated acute pulmonary disorder that developed in children for P-7 three months 柳沢龍1), 坂下一夫1), 小野貴子2), 立澤有香2), 下平滋隆3),4) Japanese Journal of Transfusion and Cell Therapy 62(2): 342-342, 2016. |
|---|
|
|
The present conditions of the P-8 examination for patient samples in the side effect (TRALI/TACO is excluded) that is non-hemolytic 平力造, 石野田正純, 梶本昌子 Japanese Journal of Transfusion and Cell Therapy 62(2): 342-342, 2016. |
|---|
|
|
Examination about the P-9 erythrocyte transfusion-related anaphylactic shock 山崎聡1), 藤本純子2), 新郷知子2), 永田雅博2), 岡村精一1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 343-343, 2016. |
|---|
|
|
One patient who presented with respiratory disorder after P-10 transfusion 村山広道1), 扇屋大輔1), 山口瞳2), 前沢由美子2), 櫻井朋美2), 小山暁史2), 杉本達哉2), 中塩屋千絵2), 板垣浩行2), 武井美恵子2), 土田文子2), 小林信昌2), 吉場史朗1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 343-343, 2016. |
|---|
|
|
2 cases that developed serious respiratory failure after P-11 blood products transfusion 村田理恵, 杉山寛貴, 中西由紀, 大塚真哉, 小野本仁美, 入江玲子, 藤田典子, 前田和宏, 池本純子, 吉原哲, 藤盛好啓 Japanese Journal of Transfusion and Cell Therapy 62(2): 344-344, 2016. |
|---|
|
|
Analysis of the case that showed elevated blood pressure after P-12 TACO and transfusion 鎌倉丈紘1), 田中陽子1), 嘉成孝志1), 関戸啓子1), 鈴木実1), 伊藤利一1), 田中朝志2) Japanese Journal of Transfusion and Cell Therapy 62(2): 344-344, 2016. |
|---|
|
|
The case that caused respiratory disorder just after P-13 transfusion 森本剛史, 松波紀行, 脇坂志保 Japanese Journal of Transfusion and Cell Therapy 62(2): 345-345, 2016. |
|---|
|
|
Analysis of the HCV-positive volunteer blood donor in P-14 Kyushu District 竹本謙一1), 藤村佳世子1), 中野稔1), 大野徹也1), 田久保智子1), 江崎利信1), 迫田岩根1), 入田和男1),2), 清川博之1) Japanese Journal of Transfusion and Cell Therapy 62(2): 345-345, 2016. |
|---|
|
|
Effect on hepatitis E virus-positive rate in the volunteer blood donor in Hokkaido by the P-15 pig raw diet prohibition 坂田秀勝1), 飯田樹里1), 松林圭二1), 伊原弘美1), 佐藤進一郎1), 加藤俊明1), 山本哲2), 池田久實2), 紀野修一1), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 346-346, 2016. |
|---|
|
|
Analysis of the HCV infection suspected case said to that causation with the P-16 transfusion was extremely low 高橋勉, 古居保美, 平力造 Japanese Journal of Transfusion and Cell Therapy 62(2): 346-346, 2016. |
|---|
|
|
Tentative plan ... of quality administration - manufacture method and QC of the P-17 cryoprecipitate 大石晃嗣, 田中由美, 松本剛史 Japanese Journal of Transfusion and Cell Therapy 62(2): 347-347, 2016. |
|---|
|
|
The use situation of the allogeneic cryoprecipitate in the P-18 our hospital 細川真梨, 成田香魚子, 加藤愛美, 郷野辰幸, 岩木啓太, 石岡夏子, 阿部真知子, 関修, 佐藤裕子, 工藤善範, 藤原実名美, 張替秀郎 Japanese Journal of Transfusion and Cell Therapy 62(2): 347-347, 2016. |
|---|
|
|
Examination about the usefulness of the Fibrinogen preparation for the P-19 obstetrics massive bleeding 松永茂剛1), 酒井あゆみ1), 阿南昌弘2), 江良澄子1), 小野義久1), 高井泰1), 山本晃士2), 関博之1), 前田平生1) Japanese Journal of Transfusion and Cell Therapy 62(2): 348-348, 2016. |
|---|
|
|
Examination of the case that required massive blood transfusion by P-20 off pump coronary bypass surgery 渡辺卓 Japanese Journal of Transfusion and Cell Therapy 62(2): 348-348, 2016. |
|---|
|
|
About the urgent O-type erythrocyte transfusion enforcement situation in the P-21 our hospital 佐藤郁恵, 佐々木綾子, 熊谷美香子, 能登谷武, 藤島直仁, 高橋勉 Japanese Journal of Transfusion and Cell Therapy 62(2): 349-349, 2016. |
|---|
|
|
Examination about the expectant mothers case who needed transfusion in our P-22 center 片山徹1), 森理紗1), 江口政志1), 稲岡千佳子1), 安井昌博1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 349-349, 2016. |
|---|
|
|
Clinical correspondence of the central nervous system bleeding during antithrombocytic agent internal use judging from P-23 questionary survey 鈴木裕子1), 池田和彦1), 大塚節子1), ノレットケネス1), 大戸斉1), 玉井佳子2) Japanese Journal of Transfusion and Cell Therapy 62(2): 350-350, 2016. |
|---|
|
|
An example of the antiRhD immunoglobulin administration in the neutralization purpose to the RhD-negative lying in woman who received urgent transfusion of P-24 RhD-positive red blood cell preparation 伊藤道博1), 長谷川浩子1), 山本浩子1), 田中宏一2), 酒井紫緒1), 三村尚也1), 井関徹1), 村澤利延3), 丹麻美3) Japanese Journal of Transfusion and Cell Therapy 62(2): 350-350, 2016. |
|---|
|
|
P-25 The course of the first maternal and child who held a warm self-antibody 二上由紀 Japanese Journal of Transfusion and Cell Therapy 62(2): 351-351, 2016. |
|---|
|
|
It is a 1 case using platelet concentrate HLA-LR for the surgery of the hepatocellular carcinoma with P-26 thrombasthenia 藤好麻衣, 塩塚成美, 柳場澄子, 江頭弘一, 川野洋之, 大崎浩一, 中島収 Japanese Journal of Transfusion and Cell Therapy 62(2): 351-351, 2016. |
|---|
|
|
1 case that P-27 developed idiopathic thrombocytopenic purpura (ITP) postoperatively 佐竹伊津子1), 安村敏1), 富山隆介1), 中出祥代1), 道野淳子1), 島京子1), 在田幸太郎2), 和田暁法2), 村上純2), 北島勲1) Japanese Journal of Transfusion and Cell Therapy 62(2): 352-352, 2016. |
|---|
|
|
Practice of the surgery treatment based on PBM for patients with cancer of the P-28 Jehovah's Witnesses 川元俊二 Japanese Journal of Transfusion and Cell Therapy 62(2): 352-352, 2016. |
|---|
|
|
Clinical studies to examine the effectiveness of the P-29 cryopreservation filtration concentration re-IV infusion method of ascitic fluid, the pleural effusion that we did (CART) 中林恭子, 松田和樹, 千野峰子, 岡本好雄, 槍澤大樹, 菅野仁 Japanese Journal of Transfusion and Cell Therapy 62(2): 353-353, 2016. |
|---|
|
|
Non-Hodgkin lymphoma who had the cold agglutinin disease of the P-30 altitude 大岩加奈, 岸愼治, 大藏美幸, 松田安史, 浦崎芳正, 山内高弘 Japanese Journal of Transfusion and Cell Therapy 62(2): 353-353, 2016. |
|---|
|
|
Transient leukocyte work increase at the sustained G-CSF preparation (Gee raster) administration for the P-31 non-Hodgkin's lymphoma (NHL) chemotherapy 山崎雅英 Japanese Journal of Transfusion and Cell Therapy 62(2): 354-354, 2016. |
|---|
|
|
Transfusion therapy for the P-32 blood vessel immunoblast-related T-cell lymphoma 橋本ひろみ1), 冨田孝子1), 南陽介3), 杉本健2) Japanese Journal of Transfusion and Cell Therapy 62(2): 354-354, 2016. |
|---|
|
|
Erythrocyte transfusion for the autoimmune haemolytic anaemias case with P-33 complications 奥田慎也1), 朝倉信之介2), 家久来侑奈2), 竹林ちあき1) Japanese Journal of Transfusion and Cell Therapy 62(2): 355-355, 2016. |
|---|
|
|
Examination of the hyperferremia of the deferasirox era in P-34 transfusion-dependent MDS and the AA and the survival / cause of death 岡本晃直1), 加藤友理2), 村松知佳2), 松浦秀哲2), 荒川章子2), 杉浦縁2), 徳田倍将1),2), 森島聡子1),2), 水田秀一1),2), 赤塚美樹1),2), 恵美宣彦1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 355-355, 2016. |
|---|
|
|
P-35 "Miracle" brought about by iron chelate by deferasirox 西尾充史1),2), 坂口良典2), 藤田奈々2) Japanese Journal of Transfusion and Cell Therapy 62(2): 356-356, 2016. |
|---|
|
|
One case that we were able to identify when caused by the blood products which HBs antibody rose after transfusion of P-36 irradiation platelet concentrate liquid -LR, and were transfused 堀内俊克1), 佐藤謙1),2), 高野昂佑1), 長尾茂輝1), 岡田陽介1), 田地規朗1), 寺本昌弘1), 加藤章一郎1), 嵯峨玲奈1), 前川隆彰1), 山村武史1), 渡邉純一1), 岩永幸子2), 坂口武司2), 小林彩香1), 小林真一1), 木村文彦1) Japanese Journal of Transfusion and Cell Therapy 62(2): 356-356, 2016. |
|---|
|
|
About the present conditions of the transfusion of the small medical institution which we saw from an MR activity of the P-37 blood center 森下勝哉1), 葛間一裕1), 紀野修一1), 牟禮一秀1), 山本哲2), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 357-357, 2016. |
|---|
|
|
Report of efforts three years to P-38 manual common knowledge 坂田由美, 清水陽平, 中島拓巳, 深澤徳行 Japanese Journal of Transfusion and Cell Therapy 62(2): 357-357, 2016. |
|---|
|
|
You give you blood of the P-39 person of duty with "the instruction text for beginner workshops", and train 安藤俊 Japanese Journal of Transfusion and Cell Therapy 62(2): 358-358, 2016. |
|---|
|
|
Efforts of authorized transfusion laboratory technician study measures by the P-40 Kagoshima medical technologist society 植村由紀1), 舞木弘幸2), 永重政人3), 川上保浩4), 今堀貴之5), 宮下幸一郎6), 田之頭敏志7), 宝代聡美5), 櫛田千晴8), 園雪絵9), 長野クミ9), 尾前歩2), 外室喜英2) Japanese Journal of Transfusion and Cell Therapy 62(2): 358-358, 2016. |
|---|
|
|
Holding of the P-41 Kobe transfusion immunity meeting for the study 橋本誠1), 楠本壽子2), 間柴祐子3), 石田美保4), 山下るり代5), 山川昭彦6), 松山貴司7), 毛利衣子8), 相原麻里9), 上村真理子9), 冨田孝子10), 橋本ひろみ10), 松谷卓周11) Japanese Journal of Transfusion and Cell Therapy 62(2): 359-359, 2016. |
|---|
|
|
P-42 The best part of the international conference[Machine Translation] (国際会議の醍醐味) Kenneth NOLLET1), 北澤淳一2), 皆川敬治1), 長谷川有史1), 大戸斉1) Japanese Journal of Transfusion and Cell Therapy 62(2): 359-359, 2016. |
|---|
|
|
P-43 Construction of the blood transfusion service revenue management system that utilizes a blood transfusion inspection system 福島靖幸, 岩本ちづる, 中野勝彦, 川野亜美, 山田枝里佳, 井手大輔, 前田岳宏, 菅野知恵美, 椿本祐子, 金光靖, 前川清, 芦田隆司 Japanese Journal of Transfusion and Cell Therapy 62(2): 360-360, 2016. |
|---|
|
|
Irregular antibody detection situation second report in P-44 Keio University Hospital 鳥海綾子1), 上村知恵1), 五十嵐靖浩1), 松橋博子1), 浅尾裕美子1), 桑原靖子1), 小池留以1), 尾崎秋乃1), 女ヶ沢遥1), 上村亜依吏1), 弥永侑子1), 渡邊直英2), 半田誠2) Japanese Journal of Transfusion and Cell Therapy 62(2): 360-360, 2016. |
|---|
|
|
We look at the rear about the detection frequency of the clinically important antibody in the P-45 our hospital and examine a mark 大友直樹, 小林志帆, 臼井友香里, 奥山馨, 古谷江梨子, 諏訪志穂子, 梶原道子 Japanese Journal of Transfusion and Cell Therapy 62(2): 361-361, 2016. |
|---|
|
|
A case and the clinical course that an irregular antibody became positive after P-46 transfusion 菅野知恵美1), 岩本ちづる1), 中野勝彦1), 福島靖幸1), 川野亜美1), 山田枝里佳1), 井手大輔1), 前田岳宏1), 椿本祐子1), 金光靖1), 前川清1), 芦田隆司1), 松村到2) Japanese Journal of Transfusion and Cell Therapy 62(2): 361-361, 2016. |
|---|
|
|
It is ... from the posttransfusion follow-up of the antiE possession patients with positive only two steps of examination - ficin method of the P-47 irregularity test for antibodies enzyme method 海老田ゆみえ1), 浦崎芳正1), 小林洋子1), 田中佐知子1), 増永志穂1), 岸慎治2), 岩崎博道1) Japanese Journal of Transfusion and Cell Therapy 62(2): 362-362, 2016. |
|---|
|
|
Titration using all P-48 automatic transfusion testing systems 渡邊友美1), 加藤千秋1), 武村和哉1), 遠藤比呂子1), 松下正2) Japanese Journal of Transfusion and Cell Therapy 62(2): 362-362, 2016. |
|---|
|
|
Examination of 65 cases that became the close inspection with blood grouping difficulty in P-49 our hospital for the past five and a half years 杉邑俊樹, 長谷川真弓, 隅志穂里, 下村志帆, 馬場由美, 辻内智美, 前田美和, 早川正樹, 松本雅則 Japanese Journal of Transfusion and Cell Therapy 62(2): 363-363, 2016. |
|---|
|
|
Case with the antie autoantibody which does not raise intravascular haemolysis found by P-50 pre-operative examination 南里隆憲1), 野田祐絵1), 深谷陽子2), 大矢健一2), 脇田充史1) Japanese Journal of Transfusion and Cell Therapy 62(2): 363-363, 2016. |
|---|
|
|
The case that participation of the platelet transfusion was suggested in a secondary immune response of P-51 HLA antibody production and antiE 阿部操, 山岡学, 樫本梨沙, 大澤眞輝, 井上まどか, 寺嶋由香利, 大西修司, 伊藤量基, 野村昌作 Japanese Journal of Transfusion and Cell Therapy 62(2): 364-364, 2016. |
|---|
|
|
One case that showed false-positive by adding a commercial reaction accelerator in P-52 indirect antiglobulin test 山岡愛子1), 平岡朝子1), 栗田絵美1), 河野真由1), 野間慎尋1), 廣瀬祥子1), 小松真由美1), 平野洋子3), 山崎尚也2), 齋藤誠司2), 藤井輝久2) Japanese Journal of Transfusion and Cell Therapy 62(2): 364-364, 2016. |
|---|
|
|
Examination about the stirring condition warming for 37 degrees Celsius 60 minutes to be carried out by P-53 response enhancer no addition - indirect antiglobulin test 村井良精1), 遠藤輝夫1), 盛合美加子1), 柳原希美2), 高橋聡1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 365-365, 2016. |
|---|
|
|
An example of patients with R1R2 which racked its brains about correspondence of the transfusion by the antibody specificity change of the P-54 Rh system autoantibody 谷口容1),2), 高橋眞奈美1),2), 燈明奈緒1),2), 前越大5), 飯田浩充3), 齋藤俊樹2),3),4) Japanese Journal of Transfusion and Cell Therapy 62(2): 365-365, 2016. |
|---|
|
|
The detection of the alloantibody by the autoantibody PEG adsorption method using the P-55 antigen known allogeneic red blood cell 安田広康1),2), 川畑絹代2), 小野智2), 斎藤俊一2), 奥津美穂2), 菅原亜紀子2), 野地秀義3), 池田和彦2),3), 大戸斉2) Japanese Journal of Transfusion and Cell Therapy 62(2): 366-366, 2016. |
|---|
|
|
AntiIgA, antiIgM support the transfusion to the patients who became positive together by P-56 direct antiglobulin test 松尾友仁, 藤田江美, 石山和樹, 清水彩, 高四強, 安藤高宣, 林恵美, 片井明子, 丹羽玲子, 高橋美裕希, 中山享之, 加藤栄史 Japanese Journal of Transfusion and Cell Therapy 62(2): 366-366, 2016. |
|---|
|
|
One case of hemolytic anemia that held P-57 cold expression autoantibody 丸山美津子1), 角屋佳苗1), 田中由美1), 西尾緑1), 森口洋子1), 櫻井亜梨紗1), 松本剛史1), 大石晃嗣1), 杉本由香2), 加藤静帆3), 伊藤正一4) Japanese Journal of Transfusion and Cell Therapy 62(2): 367-367, 2016. |
|---|
|
|
One case of seven months infants leukemia that detected antiE antibody after P-58 same kind erythrocyte transfusion after birth 久米田麻衣, 小山内崇将, 金子なつき, 田中一人, 山形和史, 玉井佳子, 伊藤悦朗 Japanese Journal of Transfusion and Cell Therapy 62(2): 367-367, 2016. |
|---|
|
|
One case of fetal erythroblastosis (HDN) attributable to the irregular antibody of plural P-59 石渡愛実1), 中村和代1), 飯田文緒1), 倉田由美子1), 佐々木尚武1), 深川良子1), 小倉亜砂巳2), 菅谷文乃2), 竹森美紀2), 青木茂3), 藤澤信4), 野崎昭人1) Japanese Journal of Transfusion and Cell Therapy 62(2): 368-368, 2016. |
|---|
|
|
Two cases of the pregnant woman that an irregular antibody for the P-60 low frequency antigen was detected 進藤聖子, 秋山友子, 大槻郁子, 尾島佐恵子, 小林美佳, 小幡隆, 小野崎文子, 中木陽子, 菅野直子, 岸野光司, 岡塚貴世志, 室井一男 Japanese Journal of Transfusion and Cell Therapy 62(2): 368-368, 2016. |
|---|
|
|
About a case given erythrocyte transfusion to a low weight child born by irregular antibody possession derived from P-61 mother 堀淑恵1), 丹野純子1), 中川知佐子1), 芳村浩明1), 増岡秀一2) Japanese Journal of Transfusion and Cell Therapy 62(2): 369-369, 2016. |
|---|
|
|
About the review of usefulness of P-62 ID-DiaPanel-P and the irregular antibody screening reexamination procedure 畑山祐輝, 松本智子, 浜田映子, 小島奈央, 原文子, 本倉徹 Japanese Journal of Transfusion and Cell Therapy 62(2): 369-369, 2016. |
|---|
|
|
Consideration about basic examination of P-63 Ortho Vision and Ortho Auto Vue Innova and two operation 金子強1), 藤原孝記1), 大曽根和子1), 難波宏美1), 蟹井はるか1), 笠井英利1), 永友ひとみ1), 灰野夏澄1), 前島理恵子1), 冨山秀和1), 松本謙介2), 白藤尚毅2) Japanese Journal of Transfusion and Cell Therapy 62(2): 370-370, 2016. |
|---|
|
|
The present conditions (comparison of a glass beads column method, the gel column method) of the P-64 irregularity antibody detection 川畑典子, 中村寛, 齋藤崇博, 豊田茂雄 Japanese Journal of Transfusion and Cell Therapy 62(2): 370-370, 2016. |
|---|
|
|
Examination of the enzyme Coombes method who assumed the gel column syphilo-agglutination test in the examination of P-65 irregularity antibody screening a principle 小田原聖1), 高舘潤子1), 千葉拓也1), 外川洋子1), 佐々木さき子1), 後藤健治1), 鈴木啓二朗2), 諏訪部章2) Japanese Journal of Transfusion and Cell Therapy 62(2): 371-371, 2016. |
|---|
|
|
It is Passenger lymphocyte syndrome after P-66 ABO blood group mismatch same kind hematopoietic stem cell transplantation: 1 case that developed PLS 大矢未来, 岡崎江里子, 森山昌彦, 間由紀, 石橋小百合, 西村加世, 中川美子, 原口京子, 奥山美樹 Japanese Journal of Transfusion and Cell Therapy 62(2): 371-371, 2016. |
|---|
|
|
ABO main mismatch allogeneic marrow transplantation not to shift to a donor blood type for P-67 long term 内海真紀1), 佐藤英洋1), 宮川英子1), 安江静香1), 中尾眞二2), 山崎宏人1) Japanese Journal of Transfusion and Cell Therapy 62(2): 372-372, 2016. |
|---|
|
|
The antiKu possession case that experienced P-68 Ko frozen thawed red flood cell liquid transfusion 山田攻1), 鈴木雅之1), 内野富美子1), 小林清子2), 池淵研二1), 岡田義昭1) Japanese Journal of Transfusion and Cell Therapy 62(2): 372-372, 2016. |
|---|
|
|
1 case of the urgent random transfusion to P-69 antiJra-positive patients 岩崎康治 Japanese Journal of Transfusion and Cell Therapy 62(2): 373-373, 2016. |
|---|
|
|
Group specificity of the P-70 ABO blood group system gene enhancer element haplotype 佐野利恵, 中島たみ子, 高橋遥一郎, 小湊慶彦 Japanese Journal of Transfusion and Cell Therapy 62(2): 373-373, 2016. |
|---|
|
|
An example of the Bm type which accepted deletion in P-71 red blood cell-specific enhancer element domain 小田晃1), 平島瑞子1), 石井博之1), 木村恵子1), 伊佐和美2), 小笠原健一2), 松倉晴道1), 藤村吉博1) Japanese Journal of Transfusion and Cell Therapy 62(2): 374-374, 2016. |
|---|
|
|
An example of the B3 type which resulted from the single base substitution of the promoter domain of the P-72 ABO gene 伊藤正一1), 荻山佳子1), 鈴木光1), 峯岸正好1), 清水博1), 伊佐和美2), 小笠原健一2), 内川誠3), 高橋遥一郎4), 佐野利恵4), 中島たみ子4), 小湊慶彦4) Japanese Journal of Transfusion and Cell Therapy 62(2): 374-374, 2016. |
|---|
|
|
The case that racked its brains about a blood grouping by P-73 antigen attenuation 深堀道俊1), 山口真紀2), 小田秀隆3), 大崎浩一2),4) Japanese Journal of Transfusion and Cell Therapy 62(2): 375-375, 2016. |
|---|
|
|
KLF1 mutation in the gene approved in the In (Lu) type of the P-74 Japanese 河井妙保1), 金子悦子1), 松田充俊1), 小野寺孝行1), 小原久美1), 榎本隆行1), 内川誠1), 峰岸清1), 稲葉頌一1), 中島一格1), 小笠原健一2) Japanese Journal of Transfusion and Cell Therapy 62(2): 375-375, 2016. |
|---|
|
|
Monoclonal antiP1 derived from a mouse indicating an only homomating type red blood cell and the agglutination of the P-75 P1 allele 鈴木由美1), 佐々木佳奈2), 海透紗弥佳1), 豊田智津1), 常山初江1), 矢部隆一1), 鈴木雅治1), 小笠原健一2), 内川誠1), 中島一格1) Japanese Journal of Transfusion and Cell Therapy 62(2): 376-376, 2016. |
|---|
|
|
About the albumin preparation reduction situation of the P-76 our hospital 鈴木美樹 Japanese Journal of Transfusion and Cell Therapy 62(2): 376-376, 2016. |
|---|
|
|
Investigation of the use of albumin preparation situation based on P-77 new guidelines 辻隆宏1), 前田浩2) Japanese Journal of Transfusion and Cell Therapy 62(2): 377-377, 2016. |
|---|
|
|
Efforts of the use situation and the proper use of the albumin preparation in the P-78 Tohoku University Hospital 関修, 成田香魚子, 加藤愛美, 細川真梨, 郷野辰幸, 岩木啓太, 阿部真知子, 石岡夏子, 佐藤裕子, 工藤善範, 藤原実名美, 張替秀郎 Japanese Journal of Transfusion and Cell Therapy 62(2): 377-377, 2016. |
|---|
|
|
Promotion of the proper use by the albumin preparation uniform management in the P-79 our hospital 赤羽由貴1), 小嶋俊介1), 竹村佳代1), 古川聖美1), 堀内香与1), 下平滋隆1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 378-378, 2016. |
|---|
|
|
Use situation investigation of the tissue adhesive in the P-80 technique 櫻井朋美1), 小山暁史1), 前沢由美子1), 山口瞳1), 中塩屋千絵1), 板垣浩行1), 武井美恵子1), 土田文子1), 杉本達哉1), 小林信昌1), 扇屋大輔2), 村山広道2), 吉場史朗1) Japanese Journal of Transfusion and Cell Therapy 62(2): 378-378, 2016. |
|---|
|
|
Ammonia removal effect of the albumin preparation with the P-81 potassium adsorption filter 藤田浩1), 高田裕子2), 五十嵐朋子2), 浅香祐幸2), 中原美千代2), 大竹千晶2), 西村滋子1) Japanese Journal of Transfusion and Cell Therapy 62(2): 379-379, 2016. |
|---|
|
|
We look at the rear of the erythrocyte transfusion for neonates, children in the P-82 our hospital and examine a mark 加藤友理1), 松浦秀哲1), 永田梨奈1), 磯貝聡衣1), 村松知佳1), 荒川章子1), 倉橋美千代1), 杉浦縁1), 岡本晃直2), 水田秀一1),2), 赤塚美樹2), 恵美宣彦1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 379-379, 2016. |
|---|
|
|
Examination (the second report) about the effectiveness of the platelet transfusion using P-83 CCI 林知佳1), 鬼松幸子1), 山本直子1), 内田立身2) Japanese Journal of Transfusion and Cell Therapy 62(2): 380-380, 2016. |
|---|
|
|
Efforts of the blood products proper use in the P-84 our hospital 菊池智晶, 石野田友香, 山田茂行, 大島孝 Japanese Journal of Transfusion and Cell Therapy 62(2): 380-380, 2016. |
|---|
|
|
Examination of the transfusion proper use in the P-85 autologous stem cell grafting 岡智子1), 山崎純代2), 山本三鈴2), 谷口亜希子3), 那須文実3), 上北奈緒3), 田嶌政治1), 直川匡晴1) Japanese Journal of Transfusion and Cell Therapy 62(2): 381-381, 2016. |
|---|
|
|
The present conditions of the fresh frozen plasma (FFP) use in the P-86 public-like municipal hospital 寺田類 Japanese Journal of Transfusion and Cell Therapy 62(2): 381-381, 2016. |
|---|
|
|
Clinical support task by the P-87 transfusion part engineer 藤野惠三1), 蓮輪亮介1), 松本有紀1), 武田真一1), 田守昭博1),2), 河田則文1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 382-382, 2016. |
|---|
|
|
Problem to shorten a crossmatch in P-88 our hospital for three days 上村正巳1), 青木寿成1), 佐藤美里1), 大木直江1), 増子正義2), 牛木隆志1) Japanese Journal of Transfusion and Cell Therapy 62(2): 382-382, 2016. |
|---|
|
|
Operation and the use situation of the division preparation for children in the P-89 our hospital 杉山真由美1), 高橋和子1), 齋藤寿美1), 新井裕介1), 江田奈央子1), 長谷川雄一2) Japanese Journal of Transfusion and Cell Therapy 62(2): 383-383, 2016. |
|---|
|
|
Example that platelet preparation derived from the different blood donation of the standard of the P-90 equivalence batch number was supplied, and produced concern in electronic authentication 上條亜紀1), 大津恵1), 原田佐保1), 岩上薫1), 小峰弘美1), 黒沢英里1), 松川恵梨子2), 野崎昭人3) Japanese Journal of Transfusion and Cell Therapy 62(2): 383-383, 2016. |
|---|
|
|
Duties improvement for P-91 security to be treated with transfusion therapy 坂口武司1), 岩永幸子1), 佐藤謙1),2), 木村文彦2) Japanese Journal of Transfusion and Cell Therapy 62(2): 384-384, 2016. |
|---|
|
|
Examination of the red blood cell preparation quality for the transfusion after the P-92 pneumatic conveyance 小林清子1),2), 海老原康博1), 池淵研二2) Japanese Journal of Transfusion and Cell Therapy 62(2): 384-384, 2016. |
|---|
|
|
Shift - from efforts - branch laboratory of the safe security in P-93 transfusion duties to self-rule 天本貴広1), 藤好麻衣2), 塩塚成美2), 柳場澄子2), 江頭弘一2), 川野洋之2), 大崎浩一2), 中島収2) Japanese Journal of Transfusion and Cell Therapy 62(2): 385-385, 2016. |
|---|
|
|
Security by the P-94 semiautomatic transfusion inspection equipment introduction and the construction of the effective transfusion duties system: Efforts of the small hospital 曽我いずみ, 高橋由華, 伊崎精一 Japanese Journal of Transfusion and Cell Therapy 62(2): 385-385, 2016. |
|---|
|
|
Setup of the transfusion duties at the P-95 new establishment hospital 柴田真由美1), 佐藤文2), 関義信3) Japanese Journal of Transfusion and Cell Therapy 62(2): 386-386, 2016. |
|---|
|
|
The use situation of the red blood cell preparation in the P-96 district core hospital 鈴木久仁子1), 藤田沙耶花1), 九里孝雄2),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 386-386, 2016. |
|---|
|
|
The present conditions of transfusion management judging from P-97 2014 blood products use fact-finding and the enforcement system 牧野茂義 Japanese Journal of Transfusion and Cell Therapy 62(2): 387-387, 2016. |
|---|
|
|
About efforts decreasing the transfusion non-certification in the P-98 Shonan Kamakura General Hospital 鈴木萌子, 槇恭佑, 三浦夢摘, 渡邉智美 Japanese Journal of Transfusion and Cell Therapy 62(2): 387-387, 2016. |
|---|
|
|
In-hospital efforts in P-99 transfusion duties, the crisis control 越知則予, 小池史泰, 岩瀬友也, 谷口達也, 楠本茂, 石田高司 Japanese Journal of Transfusion and Cell Therapy 62(2): 388-388, 2016. |
|---|
|
|
The irregular card issuance to irregular antibody-positive patients in the P-100 our hospital and future problem 玉栄建次1), 青木麻衣子1), 鈴木雅之1), 内野富美子1), 山田攻1), 松本慎二2), 棚沢敬志2), 小林清子2), 池淵研二2), 岡田義昭1) Japanese Journal of Transfusion and Cell Therapy 62(2): 388-388, 2016. |
|---|
|
|
The present conditions and problems at the urgent transfusion in the P-101 our hospital 相馬真恵美1), 小倉秀充2), 中西文江3), 高橋美幸3), 宮原由佳3), 天川早百合3) Japanese Journal of Transfusion and Cell Therapy 62(2): 389-389, 2016. |
|---|
|
|
Efforts to urgent transfusion introduction in the P-102 our hospital 島貫弘美, 松浦梨沙, 宮澤郁夫 Japanese Journal of Transfusion and Cell Therapy 62(2): 389-389, 2016. |
|---|
|
|
The present conditions and problem of the P-103 O-type RBC emergency transfusion 篠原茂1), 山川朋世1), 高柳玲子1), 池田紀彦1), 簗瀬直樹1), 及川信次1),2), 神部智子3), 高橋渉1),4), 三谷絹子1),4) Japanese Journal of Transfusion and Cell Therapy 62(2): 390-390, 2016. |
|---|
|
|
About posttransfusion infection measures of the P-104 our hospital 久保田邦典, 田中祐子, 野間口由利子, 熊川みどり Japanese Journal of Transfusion and Cell Therapy 62(2): 390-390, 2016. |
|---|
|
|
The enlightenment activity of the examination of posttransfusion infection in the P-105 our hospital and investigation about the study implementation situation 高橋桂子1), 関口久美子1), 小島直美1), 岡崎ゆり子1), 石井隆浩1), 沼野井恵1), 道林美里1), 大西宏明1),2), 渡邊卓1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 391-391, 2016. |
|---|
|
|
About efforts and the enforcement situation of the examination of posttransfusion infection in the P-106 Kitasato University Hospital 田部裕二1), 小本美奈1), 風間あきみ1), 高野波留美1), 正木杏奈1), 大谷慎一2) Japanese Journal of Transfusion and Cell Therapy 62(2): 391-391, 2016. |
|---|
|
|
For examination of P-107 posttransfusion infection rate of use improvement (efforts using an electronic chart) 山田聡美1), 中山良輔2) Japanese Journal of Transfusion and Cell Therapy 62(2): 392-392, 2016. |
|---|
|
|
About in-hospital efforts for the P-108 I&A certification acquisition and the significance 志磨美緒, 小松美保, 鴨川康代, 平松潔子, 南有美子, 渡邊由香理, 河野武弘 Japanese Journal of Transfusion and Cell Therapy 62(2): 392-392, 2016. |
|---|
|
|
Perform auditee of effect - Hospital Evaluation of function of the third party evaluation in P-109 transfusion duties, ISO15189, I&A; and - 森田曜江, 若山亜由美, 佐々木淳 Japanese Journal of Transfusion and Cell Therapy 62(2): 393-393, 2016. |
|---|
|
|
The T&S inflection situation of the surgery preparations blood in the P-110 our hospital 久保田友晶, 岡本好雄, 槍澤大樹, 小林博人, 菅野仁 Japanese Journal of Transfusion and Cell Therapy 62(2): 393-393, 2016. |
|---|
|
|
An effect to disposal blood reduction by the P-111 Type & Screen promotion and future problem 並木浩信, 松本侑己, 山下和泉, 萩原知恵, 山口知佳穂, 檀野裕子, 宮坂喜代美, 田村美智子, 相馬史, 川平宏, 田中博, 八田善弘 Japanese Journal of Transfusion and Cell Therapy 62(2): 394-394, 2016. |
|---|
|
|
About the red blood cell preparation waste ratio reduction by the T&S modi operandi change in the P-112 our hospital 小川寿代1), 佐藤克亘1), 岡田尚子2), 土屋達行1) Japanese Journal of Transfusion and Cell Therapy 62(2): 394-394, 2016. |
|---|
|
|
Efforts of the disposal blood reduction in the P-113 our hospital 佐野文紀, 荒井真, 橋本光三 Japanese Journal of Transfusion and Cell Therapy 62(2): 395-395, 2016. |
|---|
|
|
About an effect by shortening of attempt - transfusion preparation custody period of the transfusion preparation waste ratio improvement in the P-114 our hospital 山田俊樹1), 饗庭桂子2), 福岡玲2), 大野里美2) Japanese Journal of Transfusion and Cell Therapy 62(2): 395-395, 2016. |
|---|
|
|
About the present conditions and a problem of the autotransfusion in three prefectures of P-115 Hokuriku 塩原康司1),2), 彼谷裕康1), 安村敏1), 寺崎靖1), 黒川敏郎1), 経田克則1), 又野禎也1), 冨田章代1), 島京子1), 山田智恵美1), 浜田麻由子1), 道野淳子1), 南部重一1), 山谷明子1), 二正寺宏美1), 川田惠子1),2), 横川博1),2), 塩原信太郎3), 豊岡重剛4) Japanese Journal of Transfusion and Cell Therapy 62(2): 396-396, 2016. |
|---|
|
|
The present conditions and problem of the autotransfusion in the P-116 our hospital 彼谷裕康1), 石黒ひろみ2), 冨田章代2), 丸山敬子2), 河内芳美2), 中林明子2), 浜田麻由子3) Japanese Journal of Transfusion and Cell Therapy 62(2): 396-396, 2016. |
|---|
|
|
The present conditions and the prospects of the self-blood in the P-117 our hospital 小峰弘美1), 原田佐保1), 黒沢英里1), 岩上薫1), 大津恵1), 松川恵梨子2), 上條亜紀1) Japanese Journal of Transfusion and Cell Therapy 62(2): 397-397, 2016. |
|---|
|
|
The results of the obstetric self-blood drawing blood in the P-118 our hospital 藤田浩1), 高田裕子2), 五十嵐朋子2), 浅香祐幸2), 中原美千代2), 大竹千晶2), 西村滋子1) Japanese Journal of Transfusion and Cell Therapy 62(2): 397-397, 2016. |
|---|
|
|
It is investigation of ... uneasiness factor and examination ... for vagal reflex (VVR) generating reduction at the P-119 pre-operative autologous blood donation 杉浦利美, 山本敦子 Japanese Journal of Transfusion and Cell Therapy 62(2): 398-398, 2016. |
|---|
|
|
In reference to an example of the examination - BEP therapy combination peripheral blood stem cell sampling about the peripheral blood stem cell sampling at the chemotherapy that P-120 myelosuppression is slight 前川隆彰1), 高野昂佑1), 岡田陽介1), 田地規朗1), 寺本昌弘1), 堀内俊克1), 嵯峨玲奈1), 加藤章一郎1), 山村武史1), 渡邉純一1), 石関香織2), 岩永幸子2), 坂口武司2), 小林彩香1), 小林真一1), 佐藤謙1), 木村文彦1) Japanese Journal of Transfusion and Cell Therapy 62(2): 398-398, 2016. |
|---|
|
|
Change of various CD4-positive T cell in the allogeneic hematopoietic stem cell transplantation recipient after the P-121 advanced age / thymectomy 池田和彦1),2), 斎藤俊一1), 高橋裕志2), 小川一英2), 大戸斉1) Japanese Journal of Transfusion and Cell Therapy 62(2): 399-399, 2016. |
|---|
|
|
Attempt of the autologous peripheral blood stem cell sampling after the VTD-PACE therapy for patients with P-122 multiple myeloma 栂野富輝, 竹下昌孝, 谷村聡, 平井理泉, 関根理恵子, 萩原將太郎 Japanese Journal of Transfusion and Cell Therapy 62(2): 399-399, 2016. |
|---|
|
|
One case that presents mixed chimera after P-123 peripheral blood CD34-positive cells transplant for a long term 舞木弘幸, 外室喜英, 尾前歩, 宮元珠華, 古川良尚 Japanese Journal of Transfusion and Cell Therapy 62(2): 400-400, 2016. |
|---|
|
|
Tandem autologous / allograft in our hospital for the P-124 multiple myeloma 岩井俊樹1),2), 中川博子1), 宮越真由美3), 多気秀和4), 大西重樹1),4), 内山人二1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 400-400, 2016. |
|---|
|
|
An example of the hepatosplenic type T-cell lymphoma which became the molecular genetic remission by P-125 haplo transplant 黒川敏郎, 望月果奈子 Japanese Journal of Transfusion and Cell Therapy 62(2): 401-401, 2016. |
|---|
|
|
The ABO incompatibility hematopoietic stem cell transplantation case that antiA, antiB continued after P-126 survival 山岡学, 阿部操, 樫本梨沙, 大澤眞輝, 井上まどか, 寺嶋由香利, 大西修司, 伊藤量基, 野村昌作 Japanese Journal of Transfusion and Cell Therapy 62(2): 401-401, 2016. |
|---|
|
|
The present conditions of the apheresis in the P-127 our hospital 柴崎哲典1),2), 大西まり1),3), 森尾志保1),3), 森恵子1),4), 山路直人1),4), 松葉勝彦4), 中村小織4), 道根るり子4), 塩谷拓也1),2), 玉木茂久1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 402-402, 2016. |
|---|
|
|
Examination of the peripheral blood stem cell mobilization efficiency from patients with myeloma in the P-128 our hospital 加畑馨1),2), 伊藤誠1), 渡邊千秋1), 上床貴代1), 米岡麻記1), 小杉瑞葉1),2), 重松明男1),2), 高橋正二郎1),2), 杉田純一2), 橋本大吾2), 山本聡4), 佐藤典宏3), 清水力1), 豊嶋崇徳2) Japanese Journal of Transfusion and Cell Therapy 62(2): 402-402, 2016. |
|---|
|
|
CD34 counts and survival in the P-129 hematopoietic stem cell transplantation 野間慎尋1), 平岡朝子1), 河野真由1), 山岡愛子1), 小松真由美1), 栗田絵美1), 廣瀬祥子1), 平野洋子2), 山崎尚也3), 齋藤誠司3), 藤井輝久3) Japanese Journal of Transfusion and Cell Therapy 62(2): 403-403, 2016. |
|---|
|
|
Usefulness of the in-hospital measurement of CD34-positive cells in the P-130 autologous peripheral blood stem cell sampling 森威典, 八木橋健太, 清水隆弘, 高野弥奈 Japanese Journal of Transfusion and Cell Therapy 62(2): 403-403, 2016. |
|---|
|
|
System management to perform P-131 hematopoietic stem cell transplantation safely 岩永幸子1), 坂口武司1), 佐藤謙1),2), 木村文彦2) Japanese Journal of Transfusion and Cell Therapy 62(2): 404-404, 2016. |
|---|
|
|
Application of the transfusion system for P-132 transplant cells management systems construction 文屋涼子1), 中桐逸博1), 岡井美樹1), 仲井富久江1), 松橋佳子2), 田坂大象3), 通山薫1), 和田秀穂1) Japanese Journal of Transfusion and Cell Therapy 62(2): 404-404, 2016. |
|---|
|
|
Present conditions report of the peripheral blood stem cell sampling in our hospital using P-133 Spectra Optia 村中彩子1), 尾坂竜也1), 藤村真理1), 功刀早沙1), 岩村ちなみ1), 坂本大1), 齋藤文護2), 中牧剛2) Japanese Journal of Transfusion and Cell Therapy 62(2): 405-405, 2016. |
|---|
|
|
Peripheral blood stem cell, lymphocytes sampling using P-134 Optia Spectra CMNC 藤井敬子1),3), 小林優人2),3), 吉岡尚徳2),3), 黒井大雅2),3), 高木尚江3),4), 池田亮3), 浅野尚美3), 小郷博昭3), 藤井伸治2),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 405-405, 2016. |
|---|
|
|
Present conditions comparison of the transfusion therapy in P-135 hematopoietic stem cell transplantation ward and the general blood ward 高木尚江1), 川村夢乃1), 小郷博昭2), 浅野尚美2), 池田亮2), 藤井敬子3),4), 小林優人2),3), 藤井伸治2),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 406-406, 2016. |
|---|
|
|
P-136 The development of quality management methods of umbilical cord-derived mesenchymal stem cells: Cryopreservation of mesenchymal stem cells in the family cord blood bank 佐藤英明, 高橋恒夫 Japanese Journal of Transfusion and Cell Therapy 62(2): 406-406, 2016. |
|---|
|
|
The P-137 Signal regulatory protein (SIRP)α1 expression inhibition K562 cells show excrescence under low serum culture 高橋伸一郎 Japanese Journal of Transfusion and Cell Therapy 62(2): 407-407, 2016. |
|---|
|
|
Establishment of the preparation for cellular therapy enforcement based on the safe security method such as P-138 regenerative therapy 高源ゆみ, 緒方康貴, 小林博人, 菅野仁 Japanese Journal of Transfusion and Cell Therapy 62(2): 407-407, 2016. |
|---|
|
|
Analysis about the change of the immunocyte in the P-139 allogeneic transfusion 山田麻里江1),2),4), 山田尚友1),2), 中尾真実1),2), 東谷孝徳1), 久保田寧2),3), 木村晋也3), 末岡榮三朗1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 408-408, 2016. |
|---|
|
|
It is ... from the experience of correspondence ... medical technologist of our hospital transfusion part in the P-140 regenerative therapy new law 青木寿成1), 上村正巳1), 佐藤美里1), 大木直江1), 増子正義2), 牛木隆志1) Japanese Journal of Transfusion and Cell Therapy 62(2): 408-408, 2016. |
|---|
|
|
Exchange blood transfusion of composition of the P-141 own institution making mixture blood and the functional analysis and emergency neonates 高橋幸博1), 長谷川真弓2), 松本雅則2) Japanese Journal of Transfusion and Cell Therapy 62(2): 409-409, 2016. |
|---|
|
|
About significance of the preparation self-support improvement measures business (hepatitis B vaccine additional inoculation program) special in P-142 2014 and a problem 國米修平1), 鹿野徳憲1), 坂本賢一1), 石丸健1), 平力造1), 紀野修一1),2), 高橋孝喜1) Japanese Journal of Transfusion and Cell Therapy 62(2): 409-409, 2016. |
|---|
|
|
About the effect of preparation self-support improvement measures special in P-143 2014 (hepatitis B vaccine additional inoculation program) 坂本賢一1), 國米修平1), 鹿野徳憲1), 石丸健1), 平力造1), 紀野修一1),2), 高橋孝喜1) Japanese Journal of Transfusion and Cell Therapy 62(2): 410-410, 2016. |
|---|
|
|
An attitude survey about the blood donation for P-144 high school students: It having been an opportunity of the blood donation 榛葉隆人1), 藤原晴美1), 保坂侑里1), 芝田大樹1), 都築茉里子1), 石塚恵子1), 古牧宏啓1), 山田千亜希1), 渡邊弘子1), 金子誠1), 室井一男2), 竹下明裕1) Japanese Journal of Transfusion and Cell Therapy 62(2): 410-410, 2016. |
|---|
|
|
The effect that the physique of the P-145 high school student gives to blood donation behavior 保坂侑里1), 藤原晴美1), 芝田大樹1), 榛葉隆人1), 都築茉里子1), 石塚恵子1), 古牧宏啓1), 山田千亜希1), 渡邊弘子1), 金子誠1), 室井一男2), 竹下明裕1) Japanese Journal of Transfusion and Cell Therapy 62(2): 411-411, 2016. |
|---|
|
|
Change of the clot organization potency in the preservation of the P-146 washing platelet 藤原満博1), 若本志乃舞1), 林宜亨1), 内藤祐1), 遠藤正浩1), 本間稚広1), 山本哲2), 池田久實2), 紀野修一1), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 411-411, 2016. |
|---|
|
|
Thrombinogenesis ability in the P-147 washing platelet 若本志乃舞1), 藤原満博1), 林宜亨1), 内藤祐1), 遠藤正浩1), 本間稚広1), 山本哲2), 池田久實2), 紀野修一2), 高本滋1) Japanese Journal of Transfusion and Cell Therapy 62(2): 412-412, 2016. |
|---|
|
|
Quality of the fresh frozen plasma which we temporarily stored at temperature except the P-148 praeservatio 森純平, 寺田あかね, 小池敏靖, 岩本澄清, 沖学, 藤村吉博 Japanese Journal of Transfusion and Cell Therapy 62(2): 412-412, 2016. |
|---|
|
|
New strategy of P-149 Kanagawa combination transfusion therapy Committee 吉場史朗1),2), 松原賢弘2),5), 寺内純一2),4), 金森平和2),3) Japanese Journal of Transfusion and Cell Therapy 62(2): 413-413, 2016. |
|---|
|
|
Later serum storage before transfusion for the main medical institution in P-150 Aomori required and questionary survey (the sixth report) about the infection testing 北澤淳一1),2), 玉井佳子2),3), 岡本道孝2),4), 柴崎至2),5), 寺井康詞郎2),6), 白戸研一2),7), 田辺健2),8), 田中一人2),3), 兎内謙始1),2), 坂本忍2),9), 本田昌樹2),10), 村上知教2),5), 阿部泰文2),5), 立花直樹1),2) Japanese Journal of Transfusion and Cell Therapy 62(2): 413-413, 2016. |
|---|
|
|
Ordering of the platelet preparation in the P-151 Saitama combination transfusion therapy Committee transfusion duties examination subcommittee and survey of the use situation 渡邉一儀1), 石上園子2), 坂口武司3), 佐藤謙4), 池淵研二5) Japanese Journal of Transfusion and Cell Therapy 62(2): 414-414, 2016. |
|---|
|
|
Fact-finding (from Ishikawa combination transfusion therapy Committee activity) for P-152 autotransfusion promotion 佐藤英洋1),2), 二木敏彦1),3), 岡本彩1),4), 谷口容1),5), 新田誠1),6), 米田真一郎1),7), 青島敬二1),8), 塩原信太郎1),9), 山崎宏人1),2), 正木康史1),10), 山下郁江1) Japanese Journal of Transfusion and Cell Therapy 62(2): 414-414, 2016. |
|---|
|
|
Efforts of fact-finding report - Mie transfusion therapy Committee using the questionnaire before the I&A inspection of the P-153 new I&A system 松本安代1), 永田幸那2),10), 足立千鶴3),10), 井上千好4),10), 丸山美津子7),10), 伊倉基子8),10), 大西まり6),10), 櫻井亜梨紗7),10), 岡田昌彦5),10), 玉木茂久6),10), 大石晃嗣7),10), 川上恵基8),10), 岡宏次1),10), 松本剛史7),10), 今井重美5),10), 南信行9),10) Japanese Journal of Transfusion and Cell Therapy 62(2): 415-415, 2016. |
|---|
|
|
Present conditions and problems - of the examination of examination of P-154 2015 Japanese Association of Medical Technologists transfusion control survey report - transfusion 三浦邦彦1), 西岡純子2), 国分寺晃3), 奥田誠4) Japanese Journal of Transfusion and Cell Therapy 62(2): 415-415, 2016. |
|---|
|
|
P-155 Hokkaido authorization transfusion laboratory technician council "transfusion testing control survey" enforcement report, the first report 坂口良典1),2), 谷越悠耶1),3), 三浦邦彦1),4), 高橋道範1),5), 大橋恒1),6), 高橋智哉1),7) Japanese Journal of Transfusion and Cell Therapy 62(2): 416-416, 2016. |
|---|
|
|
About P-156 Miyagi medical technologist society control survey of the past four years 原田恵里香1), 遠藤一弥2), 山形悟1) Japanese Journal of Transfusion and Cell Therapy 62(2): 416-416, 2016. |
|---|
|
|
We test the significance of existence of the authorized engineer from P-157 Hokkaido authorization transfusion laboratory technician council "transfusion testing control survey" enforcement report second report questionnaire results 高橋道範1),2), 谷越悠耶1),3), 坂口良典1),4), 三浦邦彦1),5), 大橋恒1),6), 高橋智哉1),7) Japanese Journal of Transfusion and Cell Therapy 62(2): 417-417, 2016. |
|---|
|
|
Focus on blood management and enforcement system and use of blood products fact-finding report - small institution in P-158 2014; and ... third report 北澤淳一1),2), 田中朝志3), 牧野茂義4), 菅野仁5), 高橋孝喜6), 半田誠7) Japanese Journal of Transfusion and Cell Therapy 62(2): 417-417, 2016. |
|---|
|
|
... to give the motivation of activity report second report - transfusion association subject authorization nurse of nurse at P-159 northeast Branch promotion Committee to 片野めぐみ1), 鈴木桂子2),3), 根津小百合2),4), 西塚和美2), 上村克子2), 塗谷智子2), 黒田敏子2), 佐藤ルミ子2), 境峰子2), 小笠原圭子2), 高橋智子2), 樋渡佳代子2), 大戸斉2),5), 北澤淳一2),5),6) Japanese Journal of Transfusion and Cell Therapy 62(2): 418-418, 2016. |
|---|
|
|
Problems and problem in the nurse duties in the P-160 transfusion, cell therapy part 落合やよい1),2), 西原みどり1), 久冨木庸子2), 下田和哉2) Japanese Journal of Transfusion and Cell Therapy 62(2): 418-418, 2016. |
|---|
|
|
The present conditions and problem about the nurse education in the P-161 blood medical service 箕野理恵, 川股久美, 茅切朋香, 赤松恵美子 Japanese Journal of Transfusion and Cell Therapy 62(2): 419-419, 2016. |
|---|
|
|
Efforts for the P-162 effect-like transfusion education 工藤小百合, 和田麻希, 戸谷亮太, 橘清香, 西山純子, 谷川悦子, 下田将司 Japanese Journal of Transfusion and Cell Therapy 62(2): 419-419, 2016. |
|---|
|
|
It is ... questionnaire results edition ... P-163 Let's world cafe 大野優輝子1), 西塚和美1), 乗田生子1), 喜多島直美1), 中山千晶1), 山片りゅう子1), 築舘ルミ子1), 菊池貴子1), 高橋慎子1), 工藤柳子1), 北澤淳一2) Japanese Journal of Transfusion and Cell Therapy 62(2): 420-420, 2016. |
|---|
